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INTRODUCTION 
Preamble 
The significance of heavy metals to the health of man and 
animals has been a subject for extensive speculation. Review 
of the literature clearly points out that excessive intake of 
lead and its compounds may lead to clinical toxicosis and 
death. Cadmium and mercury have also been implicated as heavy 
metals hazardous to the public health. According to Chisolm 
(1971), "among the natural substances that man concentrates in 
his immediate environment, lead is one of the most ubiquitous". 
The scientific literature is replete with reports on the toxic 
manifestations of lead poisoning; however, the significance of 
quantities of lead that do not produce clinical toxicity has 
remained a subject for extensive speculation by public health 
officials. Included in this speculation have been suggestions 
that subclinical levels of lead and other heavy metals may 
produce adverse effects on man and animals. Unfortunately, 
the specific effects of lead at subclinical levels upon the 
mammalian system have not been fully determined. Yet, it is 
clearly recognized that a large percentage of our human and 
animal populations is constantly exposed to appreciable quanti­
ties of this heavy metal. 
Vertebrates normally are equipped with powers of re­
sistance which are of fundamental importance to survival of 
the individual. This resistance or immunity, as it is called. 
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resides in part in the cellular elements of tissues and in 
part in antibodies in the blood stream. The immune system 
is not only well organized but is highly efficient and is 
thought to be mediated by a complex interaction of natural 
and acquired immunologic factors. Lead may alter or provoke 
an impairment in one or more of the major mechanisms of 
immunity/ thereby producing immunologic deficiency disorders 
in susceptible human and animal populations. Such induced 
deficiency disorders could result in diminishing resistance 
to infection with organisms which previously posed little 
danger. The health of man and animals may^ indeed, be 
jeopardized to a far greater extent than now realized due 
to heavy metals reducing their resistance to various infec­
tious agents. Little attention, thus far, has been directed 
toward determining the effects and influence of lead on the 
resistance to bacterial invasion and immunologic reactivity 
of susceptible hosts. 
Williams et al. (1954) suggested that lead may inactivate 
antibodies and thereby interfere with mechanisms whereby man 
and animals resist infectious disease. Their conclusions were 
based on the study of an acute, fatal illness in a twenty-
three-month-old child with a history of eating paint. Neuro-
pathologic findings were so similar to those seen in acute 
septicemia that, in spite of concentrations of lead of 0.348 
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mg per 100 ml of blood, it was assumed that death of the 
child was due to bacterial agents that were able to grow un­
inhibited as a result of lead-mediated antibody inactivation. 
Other investigators have suggested that lead exposure might 
interfere with one or more specific immunologic mechanisms 
(Hemphill et 1971, Paljnieniak.and SrodliJc, 1963; Rakhimova, 
1968; Soliman et , 1970; Sroczynski ^  al., 1964; Tepper 
and Pfitzer, 1970). Binding of serum proteins and gamma­
globulins , for example, could remove antibodies from the 
circulation. Fonzi et (1967) reported that lead-treated 
animals, subsequently subjected to procedures of active immuni­
zation, developed lesser quantities of gamma-globulin; comple­
ment levels as well as anti-typhoid antibody titers were 
lower. Recent evidence indicates that lead may bind to 
various enzymes (Tepper and Pfitzer, 1970) and thus could pos­
sibly interfere with physiologic processes. Further, lead 
could interfere with antibody synthesis by binding with nucleic 
acids which may be significant in the inductive phase of anti­
body formation. Evidence for a specific effect of lead upon 
the mammalian system, when absorbed in quantities that do not 
produce clinical disease, has not yet been reported. It is 
reasonable to assume, however, that at some point short of 
clinical lead poisoning, in the usual sense, body concentra­
tions of lead will reach a magnitude sufficient to cause sig­
nificant changes in normal physiologic mechanisms (Tepper and 
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Pfitzer, 1970) , 
The immunologic system of mammalian species is rather 
complex but is now well defined. Subclinical levels of lead 
have been demonstrated to influence this system and the model 
offers an excellent approach to definitive studies of the 
action of lead on a physiologic mechanism. 
Statement of Problem 
The mechanistic basis for the action of lead in increasing 
susceptibility to infectious agents has not been elucidated. 
While the pathologic and biochemical aspects of increased lead 
exposure have received extensive study^ very limited considera­
tion has been given to the effect of lead upon immunologic 
factors. Reported experimentation is limited to the work of 
Fonzi et (1967) on lowered complement levels and serum 
antibody titers in lead-treated animals, a few reports in the 
Russian literature on levels of circulating polymorphonuclear 
leukocytes, phagocytic function, and serum bactericidal activ­
ity in men exposed to toxic levels of lead (Rakhimova, 1968) 
and a single report on the ^  vitro binding of antibodies by 
lead (Williams et , 1954) . Elucidation of the mechanism(s) 
whereby lead reduces resistance to bacterial infection would 
provide evidence of a specific activity of lead on physiologic 
processes. A more comprehensive approach to treatment of cases 
of lead exposure could result. In addition to the therapeutic 
approach, preventive medicine might not only include measures 
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to reduce exposure to lead but also prophylactic procedures 
to increase resistance to infectious agents. 
With these ideas in mind, the experimentation reported 
in this dissertation was designed to provide evidence con­
cerning the immunologic factors affected by exposure to sub­
clinical levels of lead. These experiments represent a de­
tailed investigation of many preliminary observations. They 
have led to an evaluation of several immunologic parameters 
in mice to provide a more thorough comprehension of the effect 
of lead on the functional activity of various immunologic 
factors and mechanisms. 
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LITERATURE REVIEW 
Historical Concepts of Lead 
Exposure 
Probably more has been expounded about the effects of 
lead and its compounds on the human and animal system, both 
actual and by inference, than about any other element. 
Plurabism (from the Latin word for lead) or saturnism (from 
the alchemical term) was familiar to Greek, Roman and Arabian 
physicians before the Christian era. Hippocrates was credited 
as the first to associate exposure of man to lead with the 
subsequent development of clinical signs (Waldron, 1966). 
In the second century B.C., Nicander recognized lead poison­
ing and recorded its symptoms in workers that were exposed to 
the metal (Aub et , 1926; Gilfillan, 1965; Morgan et al., 
1966) . Chronic lead poisoning was incriminated as a partial 
cause for the decline of ancient Rome, where the metal was 
deliberately put into wines and certain foods and used in 
interior paints, to line cooking and drinking vessels, and 
for many other purposes not then known to be dangerous 
(Gilfillan, 1965). Throughout the ages, repeated reference 
was made to lead and its effects, as recorded in the writings 
of Sir George Baker in 1767 (The Devonshire Colic), Tanquerel 
des Planches in 1839 (Treatise on Lead Poisoning), and Rumpel 
in 1834 (On Lead and Its Action on the Human Body) (McCord, 
1953; Hunter, 1957). In 1922, Else Blansdorf collected and 
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published three thousand references, all dealing with the 
various aspects of lead poisoning. A much larger bibliography 
was compiled in 1943 by Florence A. Brous, and hundreds of 
papers have appeared since. In surveys such as these, and in 
recent texts and monographs, clinical literature dating back 
to at least 1840 is constantly cited. On the other hand, the 
pathologic physiology and chemistry of lead, the exact mode 
of its absorption, the changes it undergoes in the body, the 
manner of its action, its storage and excretion, and the 
changes it produces (other than gross alterations).in the 
body tissues have only received intensive study in the past 
thirty-five years. 
While much of the best modern research in plumbism has 
been conducted in Germany, England, the United States and 
the Soviet Union, the foundations of our modern knowledge of 
the subject were laid in France. Bonté (1764) during the 
eighteenth century gave excellent descriptions of the 
symptoms of plumbism, with special reference to the paralyses. 
In 1803, Mérat de Vaumartoise published a treatise on the 
same theme, which was considered the best of its kind as re­
gards clinical description of the acute states of lead toxi­
cosis . A large number of French authors contributed papers 
in which specific aspects were discussed. 
Augustin Grisolle published an essay on the colic, 
describing about fifty cases as seen in white-lead workers 
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(Grisolle, 1835). Still more important were Grisolle's 
studies of lead encephalopathy (Grisolle, 1837). In describ­
ing with care the delirious, epileptiform and comatose mani­
festations, he left relatively little to be improved upon by 
his successors. 
The valuable work of the early French students of plumbism 
culminated in the epoch-making treatise of L. Tanguerel des 
Planches (1839). Tanguerel carried out his work in the 
Charité, long famous for its treatment of metallic colic. 
His comprehensive statistical study was made possible by 
the abundance of clinical material in the Charité wards, 
where 1217 cases of lead colic were treated between 1831 and 
1839. White-lead work was responsible for 406 of the cases, 
painting for 382, red-lead for 75, color grinding for 68, 
potteries for 61, lapidaries for 35, refining for 25, German 
glazed card making for 11, making lead salts for 10, and 
fifteen (15) other trades had jass than 10 each. Arthralgia 
was observed in 755 cases, paralysis in 127, and encephalo­
pathy in 72 (Tanquerel des Planches, 1839). Not only did 
Tanguerel report in this way on the occupational aspects of 
lead poisoning, he also supplied comparative numerical studies 
of the occurrence of different symptoms. Tanguerel's clinical 
observations in man were very accurate and not much of im­
portance has since been added to them. This is best ap­
preciated by noting how frequently his century-old treatise 
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is still quoted in the literature of today. 
It was not until the nineteenth century that the various 
"endemic" colics with the characteristics of lead colic began 
to be generally appreciated for what they really were. For 
the long delay three chief reasons are suggested: (1) failure 
to appreciate the importance of idiosyncracy, a still un­
explained phenomenon, in the incidence of lead poisoning; 
(2) the difficulty of tracing the toxic metal when absorbed 
in small amounts, often from unsuspected sources; (3) the 
absence of easily recognizable signs in the pathologic anatomy 
of plumbism. Practically all of the early reports on the 
pathologic anatomy of plumbism were extremely variable and 
they undoubtedly included many abdominal inflammatory condi­
tions and cerebral pathology of a nonspecific kind or of a 
different etiology. There were also, however, reports of 
completely negative findings. Gabriel Andral (1839) reported 
post-mortem observations on ten patients who had died with 
plumbism (although in several instances death was due to 
trauma or other causes). He found no significant changes and, 
in at least two cases where death was apparently the conse­
quence of acute lead poisoning, he discerned "aucune lesion 
appreciable sur le cadavre". This was confirmed on a very 
large number of cases by Tanquerel des Planches (1839). The 
lack of correlation between the clinical picture of lead 
poisoning and the pathologic findings was such that a post­
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mortem examination was of little or no value in proving lead 
to be the immediate cause of death (Alcock, 1905). 
Industrial lead poisoning has been largely controlled, 
but accidental poisoning of children is still prevalent 
(Perlstein and Attala, 1966; Chisolm, 1971). Renewed 
interest in lead poisoning in the past ten years has led 
to more frequent diagnoses and recognition of the disease as 
a serious public health menace. Lead poisoning is reportedly 
the most common type of fatal poisoning in man (Perlstein and 
Attala, 1966). Most poisoning results from eating lead-
containing paint or plaster and occurs more frequently in 
city slums than elsewhere. Of the children who recover from 
lead poisoning, it is estimated that up to 50% have persistent 
cerebral damage ranging from subtle learning deficits to 
profound mental incompetence and epilepsy (Chisolm, 1971). 
Lead is found widely in animal and vegetable tissues, 
water, atmosphere, and is a normal constituent of the human 
diet. Intake and absorption of lead by the general popula­
tion is therefore inevitable. Excessive absorption may re­
sult in systemic poisoning. The present degree of exposure 
to lead of citizens of the United States has been termed 
"chronic lead insult" and Patterson (1965) has suggested that 
the present rate of lead intake may already be sufficiently 
great to impair health. He maintains that the concentration 
of lead in the blood of "normal" American citizens is ap­
proaching that at which symptoms of chronic poisoning may be 
expected and that the "intellectual irritability" associated 
with lead poisoning might occur to a lesser but still signifi­
cant extent in persons who are subject to chronic lead insult. 
Physiopathology of Lead 
Until recent years, when more sophisticated tests for 
aberrations in the metabolism of hemoglobin derivatives 
(hemosiderin, bilirubin and porphyrin) became available, the 
chief criteria of lead poisoning have been (1) clinical signs 
and symptoms, (2) the blood changes mentioned above, and (3) 
tissue levels of lead. 
Since lead in the feces may never have been absorbed, 
chief reliance has been placed on the detection of lead in 
the urine. Apparently the earliest reports of the diagnosis 
of lead poisoning in obscure cases by this means were two 
papers published in 1883 by J. 3. Putnam of Boston (Putnam, 
1883). Patients who showed no lead line, no colic, no emacia­
tion, and no typical extensor paralysis were observed to ex­
crete urinary lead. The presence of lead in the urine was 
regarded by most authorities as indicative of lead poisoning 
until 1926, when Kehoe and his associates introduced the con­
cept of "normal lead excretion" (Kehoe et , 1926) . In 
view of the fact that exposure to lead compounds has signifi­
cant meaning only if lead absorption occurs, numerous studies 
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have since been done on urine and blood to provide quanti­
tative information on the relationship between exposure and 
absorption. 
While a great many other pathologic changes have been 
described/ none can be selected as pathognomonic. A com­
bination of those more frequently observed is sometimes 
advanced in support of a diagnosis, but the chief importance 
of such changes has been to suggest starting points for re­
search in pathologic physiology. 
In a list of nearly forty types of lesions said to occur 
in those suffering from plumbism, Aub and his colleagues 
(1926) followed by Cantarow and Trumper (1944) selected only 
two as "lesions found constantly, due to lead." These lesions 
are the "blue line" of the gums and anemia, together with 
stippling of the erythrocytes. The "blue line" or "lead line" 
is considered to be a reliable indicator when found, but the 
lead line usually fails to develop if the teeth, gums and 
mouth are cleaned regularly. In 1910, Dr. Alice Hamilton re­
garded the line as an almost invariable occurrence; between 
1930 and 1940 she came to consider it relatively rare (Hamil­
ton, 1943) . This observation was regarded as an indication 
of changing habits in oral hygiene, since the phenomenon was 
still observed where poor oral hygiene and plumbism coin­
cided (Hamilton, 1943). 
The presence of basophilic granules in certain red blood 
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cells was first pointed out by Ehrlich (1885). He did not, 
however, remark on its association with lead poisoning. 
Credit for this correlation is usually granted solely to 
Behrend (1899). The value of punctate stippling as a diag­
nostic sign of plumbism has been much debated, and the propor­
tion of cases in which it occurs has been variously reported. 
While its absence is not considered as evidence of freedom 
from lead absorption, its presence is generally accepted as 
a diagnostic indication of prime importance both in animals 
and in man (Zook et a^., 1969). 
A less specific indicator, àneiûia, has also been reported 
in the voluminous literature of lead poisoning (Aub et , 
1926; Eriksen, 1955; Goldberg et , 1956; Hutchison and 
Stark, 1961). The diminution in the number of erythrocytes 
has been confirmed in well-developed cases of lead intoxica­
tion, but is less striking than the decrease in hemoglobin. 
The "blood picture" has been clarified, but the pathogenesis 
of these changes is not yet entirely clear. 
Numerous studies in more recent times have well charac­
terized lead poisoning in man and animals and have at­
tempted to explain much of the pathogenesis of the disease. 
Lead poisoning has been reported in dogs, cattle ; horses, 
waterfowl, sheep, swine, mink, foxes, and cats. All species 
of animals are susceptible; but due to eating habits or greater 
sensitivity, lead poisoning is more frequently observed in 
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cattle, horses, waterfowl, and dogs. Young anin^als are more 
susceptible than mature animals. Goats, chickens, and pigs 
are more tolerant (Buck et ^ ., 1973; Radeleff, 1964/ Link 
and Pensinger, 1966). 
Lead poisoning has received extensive study in the dog, 
probably due to a high incidence of the disease in this 
species. Many cases of lead poisoning in dogs have been re­
ported from Africa (Scott, 1963) and from New Zealand (Dodd 
and Staples, 1956), where the disease is "very common". It 
is also considered quite common in Britain (Wilson and Lewis, 
1963) . Lead poisoning in dogs is also widespread throughout 
the United States (Zook et ^., 1969; Bond and Kubin, 1949; 
Estrada, 1962; Lieberman, 1948; Molpus, 1958; Pettit et al., 
1956). Zook et ^ ., (1969) reported on 42 cases of acci­
dental lead poisoning in dogs where age was given, 31 were 
less than one year old, and the rest were from 15 months to 
11 years of age. It is widely believed that young dogs are 
more susceptible to lead poisoning than are old dogs, but 
this opinion seems to be based on rather tenuous evidence. 
It appears that dogs are rather commonly poisoned with lead, 
but this may be related to their bizarre eating habits re­
sulting in the ingestion of lead-containing substances (Zook 
et al., 1969) . 
Clinical signs of lead poisoning in dogs are usually 
reported as beginning with anorexia, vomiting, colic, diarrhea 
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or constipation, and often progressing to signs of nervous dam­
age such as hyperexcitability, hysterical barking, champing 
fits, convulsions, opisthotonus, paraplegia, muscular spasm, 
hyperesthesia, blindness, or behavioral changes (Bond and Kubin, 
1949; Calvery et , 1938; Dodd and Staples, 1956; Estrada, 
1962; Fauts and Page, 1942; Lieberman, 1948; Mitchell, 1940; 
Molpus, 1958; Monot, 1961; Oliver et , 1959; Pettit et al., 
1956; Scott, 1963; Staples, 1955; Wilson and Lewis, 1963; Zook 
et , 1969). Other signs mentioned include weakness, weight 
loss, sialosis, and scurfy skin (Calvery et , 1938; 
Lieberman, 1948; Wilson and Lewis, 1963). Of a total of about 
76 accidental and 51 experimental lead poisonings of dogs, a 
lead-line or Burtonian line was reported on the gums in only 
3 dogs (Zook ^  al., 1969). Discharges from the eyes and 
nose are occasionally reported, but these signs may be the 
result of concurrent infection. It has been reported that a 
number of dogs apparently suffered from distemper and lead 
poisoning simultaneously (Zook e_t al. , 1969) . 
Acute lethal single exposures are usually considered to 
be in the magnitude of 400-600 mg per kg in calves and 600-
800 mg per kg in adult cattle. However, a case has been 
reported in dairy cattle where an estimated single exposure 
of 4.8 mg per kg red oxide of lead in paint killed 18 of 20 
animals. The daily intake of approximately 6-7 mg per kg body 
weight appears to be the minimum dose which will eventually 
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give rise to toxicosis in horses and cattle. Horses are 
somewhat more susceptible than cattle (Hammond and Aronson, 
1964). Sheep were fed metallic lead daily during gestation 
at levels ranging from 0.5-16.0 mg per kg to maintain blood 
lead levels of 0.4-0.6 ppm. Severe nonfatal poisoning 
occurred, manifested by anorexia, emaciation, and abortion 
(Sharma, 19 71) . 
Although lead is poorly absorbed from the digestive tract, 
blood lead levels may rise to 2.5-4.0 ppm within 12 hours of 
ingestion and decline to 1-1.5 ppm in 4 8-72 hours. However, 
the blood level will remain elevated for one to two months 
(Allcroft, 1951). This slow decline in blood lead level 
emphasizes the slow excretion of lead in untreated animals 
and the role of lead as a chronic cumulative toxicant. 
Lead accumulates in the body so that chronic exposure 
to small amounts may lead to toxicosis. Silage containing 140 
ppm lead has poisoned cattle. Herbage grown on lead-con­
taminated soil has contained 2 60-914 ppm and caused death in 
calves. Normal herbage should contain 3-7 ppm or less. 
Forage with levels less than 40-60 ppm did not cause problems 
in lambs (Buck e^ al., 1973). 
Lead appears to affect all major organs. Circulating 
lead combines with erythrocytes and, unless in very high con­
centrations, is not found in plasma. Anemia may result 
initially from an increased fragility of red cells which leads 
17 
to premature destruction and, secondly, by depression of bone 
marrow so that fewer cells are produced (Aub et al., 1926). 
The nervous system is affected by a decreased blood supply 
due to damage to capillaries, which results in either edema 
or a collapse of the small arteries. Peripheral nerves are 
affected by a segmental demyelination which interferes with 
nerve conduction (Gombault, 1880). The roaring that is ob­
served in horses, the pharyngeal or buccal paralysis in 
cattle, and the paralysis of the masseter muscles in dogs 
are evidence of neurological damage of either cranial nerves 
or brain stem nuclei (Christian and Tryphonas, 1971). 
In the kidney, lead causes degeneration and necrosis of 
mitochondria and renal tubule cells (Watrach, 1964; Goyer, 
1968). 
Additional evidence which may be used to substantiate 
excessive lead exposure is the presence of acid-fast int' a-
nuclear inclusions in the proximal convoluted tubules of the 
kidneys and the presence of significant amounts of lead in 
tissues. Acid-fast intranuclear inclusions, however, are not 
always present and are not specific (Jubb and Kennedy, 1963; 
Christian and Tryphonas, 1971). In acute exposures, lead may 
cause necrosis of gastrointestinal mucosa. Liver degeneration 
and necrosis can follow both acute and chronic exposures 
(Hatch and Funnell, 1969). In young animals, lead will 
accumulate in metabolically active growth centers of long 
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bones (Clegg and Rylands, 1966). This results in increased 
densities on radiographs. Experimentally, lead will suppress 
growth in young animals. Lead crosses the placental barrier, 
and the fetal liver can accumulate toxic levels. Lead can 
be a cause of abortion, fetal resorption, and sterility (All-
croft, 1951). 
Lead is removed slowly from the body, primarily by the 
kidneys. For instance, sheep can excrete a maximum of 0.8 
mg lead per day in the urine. Four to six months may be re­
quired to reduce the blood lead levels to control levels 
following acute nonfatal exposure. The magnitude of biliary 
excretion of lead is poorly understood. Lead is also ex­
creted in the milk which is a potential source of the metal 
for nursing animals (Hammond and Aronson, 1964). 
The subcellular effects of lead have not been fully 
investigated. However, lead will cause rupture of lysosomes 
and release of acid phosphatase which is required for energy 
production and protein synthesis. Lead interferes with several 
enzymes involved in heme synthesis (Brun and Brunk, 1967). 
One important effect is inhibition of aiminolevulinic acid 
dehydrase (ALAD), thus blocking the metabolism of aminolevu­
linic acid (ALA), causing abnormally large amounts of delta-
aminolevulinic acid (A-ALA) to appear in the plasma and urine 
(Blumenthal et , 1972). The detection of abnormal levels 
of A-ALA in urine has been used as a diagnostic tool in human 
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and veterinary medicine. Lead also blocks the incorporation 
of iron into the heme molecule. In general, it is thought 
that lead will interfere with thiol-containing enzymes ( -
SH) (Bessis and Breton-Gorius, 1959). 
Lead has been found to enhance susceptibility of rats to 
bacterial endotoxin. It was suggested in this study that 
lead might increase endotoxin sensitivity by inactivating 
the reticuloendothelial system (Selye e;t , 1966) . Truscott 
(1970) studied the effect of lead acetate on endotoxin toxi­
city in chicks. His findings were similar to those of Selye 
et al., (1966), that lead potentiates the toxic effect of endo­
toxin . 
Binding of serum proteins by lead was reported by Matsu-
kuto (195 9). Lead-210 containing solution was incubated with 
human serum. Radioactivity was observed in the albumin and 
a 2-globulin fractions of rats injected with Lead-210. 
Lead has been shown to reduce the resistance of mice to 
bacterial infection by inhibiting antibody production or 
tying up antibodies already produced even at exposure levels 
insufficient to cause other signs of poisoning (Hemphill 
et al./ 1971). This finding could have profound influence 
upon the present attitude toward environmental contamination 
by lead, if similar effects of lead are shown in other species 
of animals. 
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Distribution and Availability 
of Lead 
Production and utilization 
Lead is produced by melting the ore galena (lead sul­
phide) . This substance is widely distributed and occurs in 
both surface and underground deposits. Production figures 
are not the best guide to utilization since there is con­
siderable recycling of this valuable metal as scrap through 
secondary smelters (Barltrop, 1969). The production and con­
sumption figures for the United States have been reported in 
detail and concern some 1,100,000 short tons per annum, of 
which about 60% is metallic lead and the remainder is in the 
wide variety of lead compounds (Ziegfeld, 1964) . The major 
industries utilizing lead are listed in Table 1, together with 
their percentage share of the total annual consumption. 
Table 1. Lead consumption by industry in the United States 
(after Ziegfeld, 1964) 
Industry % 
Storage batteries 35 
Petrol 16 
Building 11 
Brass, ceramics, type set, paint 15 
Other 23 
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From the figures cited (Ziegfeld, 1964) / it is particularly-
interesting that 175,000 tons of lead is utilized in the 
production of petrol, since much of this will eventually be 
distributed into the atmosphere as automobile exhaust. In 
addition, 2,500 tons of lead arsenate are intended for 
application to food-crops as pesticide. 
Among the many present day uses for lead are some which 
may not be easily recognized, e , lead compounds as stabil­
izers in certain plastics. New uses are continually sought 
and the application of organo-leads as biocides in wood and 
fabric preservation and even bilharzial control are being 
studied (Van der Kerk, 1966). Although organic compounds of 
lead have their own toxicity characteristic, ultimately they 
are all likely to be degraded and to release lead in the 
inorganic form. 
The industrial contribution to environmental lead may 
result from the emission of lead particles into the atmosphere 
and by pollution of natural waters with lead-containing in­
dustrial-effluents . Polluted atmosphere and water both serve 
to contaminate soil, plants and foodstuffs. Thus, both at­
mosphere and diet contribute to the daily lead intake (Barl-
trop, 1969). 
Atmospheric lead 
Since their introduction into petrol in 1923, nearly 3 
million tons of lead alkyls have been marketed (Chow and 
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Johnstone, 1965). After combustion, the anti-knock derivatives 
in petrol are released in organic form as a mixture of halides 
and oxides. Atmospheric pollution has occurred on a world 
scale and has affected even remote regions. Serial samples 
of earth and snow since 1900 have shown a sharp increase in 
lead content during recent decades (Murozumi, et a2., 1966). 
The blood lead of persons living close to regions of high 
traffic density such as motorways has been shown to be sig­
nificantly higher (22.7 ug/100 g) than that of comparable 
individuals in an area remote from heavy traffic 16.0 yg/ 
100 g). 
Although automobile exhaust fumes are a major problem 
in the Northern Hemisphere, industrial undertakings also make 
a significant contribution to atmospheric pollution. In 
areas close to lead smelters or installations for the burning 
and distillation of coal, significant atmospheric pollution 
with lead may occur and should be considered with regard to 
the local population (Barltrop, 1969) . It is seldom realized 
that the atmospheric emissions from smelters may be very 
large; Chakraborty e;t , (1964) reported one plant in India 
that discharged 2,000 pounds (907 kg) of lead into the at­
mosphere daily. A similar example in Minnesota deposited suf­
ficient lead on local foliage to precipitate acute lead 
poisoning in the local cattle and horses that consumed it 
(Hammond and Aronson, 1964). 
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Water 
Natural waters contain lead derived from ?» number of 
sources including rocks and soil, particulate matter derived 
from atmospheric fallout and, in some instances, a contribu­
tion from sewage. Variations in the lead content of waters 
occur between different geographic regions and surface water 
has been found to contain 4-20 ug per liter. These figures 
contrast with those of well water consumed by a child with 
'epilepsy' which had a lead content of 408 yg per liter 
(Oyanguren and Perez, 1966). 
Contamination of reservoirs by air pollution is probably 
not yet a major problem. However, in the Seattle, Washington 
region, it has been established that about 70 mg of soluble 
lead derived largely from road traffic exhaust rather than 
industrial sources, settles on each square meter of surface 
per month. The large volume of the reservoirs minimizes the 
effect of this fallout. In the winter, however, decreased 
utilization of water may result in a doubling of the lead 
content to 6 yg per liter (Johnson, et , 1956). Recrea-
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tional motor boats disperse 4 x 10 g of lead into natural 
waters in the United States each year from combustion of fuel 
containing lead alkyls (English, cited in Ettinger, 1967), but 
this is a small contribution compared with sewage which con-
9 tributes a further 8 x 10 g per annum. 
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The use of lead pipe, lead solder on copper pipe and 
occasionally even lead paint on water storage tanks, gives 
rise in many countries to a situation in which the lead con­
tent of the water supplies may differ greatly from the water 
actually consumed. Factors which influence the "plumbo-
solvency" of a given water include the pH and the calcium 
content. Soft acid waters are especially liable to dissolve 
lead with which they come into contact. Prolonged standing 
in a pipe may result in some lead being dissolved and water 
in the terminal lead pipes of a dwelling will have an ap­
preciably higher lead content after standing overnight. The 
World Health Organization (WHO) revised 1963 standard for 
drinking water set an upper limit of 50 yg per liter for 
lead, but the WHO "European" standard allows drinking water 
to contain up to 300 ug per liter after standing in the pipe 
for 16 hours (Barltrop, 1969). 
Radioactive lead 
Radioactive lead is continuously deposited on the earth's 
surface as part of the "natural" fallout, although it is in­
creased after atmospheric nuclear detonations. Rocks contain­
ing radium continually liberate radon into the atmosphere, 
which in turn decays through a series of shortlived isotopes 
to Lead-210. This isotope has a half-life of 22 years and 
ultimately decays through a further series of isotopes to 
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stable lead. It has been calculated that 22 x 10 atoms of 
Lead-210 are distributed over the earth's surface in this way 
each year (Lambert and Nezami ; 1961). Of significance here 
is the fact that the body cannot distinguish radioactive from 
stable lead and, since this is a bone-seeking element, the 
situation is analogous to that of the more familiar Strontium-
90. It has been shown that there is a close correlation 
between the Strontium-90 and the Lead-210 content of human 
bones (Barltrop, 1969). 
Foodstuffs 
The contribution of foodstuffs to the daily lead burden 
of the adult is of the order of 300 ug per day, but this 
is prone to local and geographical variation due to dif­
ferences in preparation and distribution (Kehoe, et al., 
1933). Some animal tissues, such as liver and kidney, have 
a special affinity for lead so that the intake of lead from 
a diet rich in these might be higher than an equivalent diet 
based upon other tissues derived from the same animal (Kehoe 
et , 1933) . 
Plants and vegetables that are grown near dense traffic 
routes are liable to contamination. Analyses of leaves taken 
from sites near highways in Great Britain have revealed mean 
lead contents of 87 mg per kg which is almost double the mean 
lead content of foliage from sites remote from traffic (45 mg/ 
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kg). The results were unrelated to the lead content of the 
soil in which the plants grew (Everett, Day and Reynolds, 
1967). A seasonal variation in the lead content of pasture 
herbage has been described by Mitchell and Reith (1966). 
During senescence a redistribution of lead ions occurs 
within the plant so that the above-ground portion may reach 
concentrations of 30-40 mg per kg during the winter compared 
with 0.3-1.5 mg per kg in the spring. Levels of 40 mg per 
kg are considered of importance to animals feeding on this 
material (Mitchell and Reith, 1966). 
The use of lead-containing pesticides has already been 
cited, especially the use of lead arsenate sprays. Associated 
with the use of lead arsenate sprays, elevated lead concen­
trations have been found in fruit, tomatoes and coffee beans 
(Barltrop, 1969) , and apples (Pocklington and Tatton, 1966). 
Studies on imported apples by the latter authors indicated 
that increased lead residues ' jre present in apples from 
countries that allow the use of lead arsenate sprays compared 
with countries that do not. Thus, apples imported from Canada 
where lead arsenate sprays are used contained as much as 
1750 pg per kg, whereas South African apples contained only 
100-300 yg per kg. 
The continued exposure of sections of the population to 
increased environmental lead levels remains a subject for ex­
tensive speculation and in the words of Chisolm (1971) , "al­
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though no population group is apparently yet being sub­
jected to levels of exposure associated with the symptoms of 
lead poisoning, it is clear that a continued rise in the pollu­
tion of the environment with lead could eventually produce 
levels of exposure that could have adverse affects on human 
and animal health." 
Today our concerns about hu-aan and animal health and the 
dissemination of lead into the environment are twofold: (1) 
there is a need to know whether or not the current level of 
lead absorption in the general population presents some 
subtle risk to health; (2) there is even more urgent need 
to control this hazard in the several subgroups within the 
general population that run the risk of clinical plumbism and 
its known consequences (Chisolm, 1971). Increased exposure 
to lead has been shown in populations exposed to lead as an 
environmental pollutant. 
The magnitude of present day environmental lead contami­
nation is emphasized by the recent calculation that 20 tons 
of lead are consumed annually by the population of the United 
States (Patterson, 1965). Some natural environmental lead is 
radioactive Lead-210 and this provides an additional hazard 
for the total body lead burden. 
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Concepts of Immunity 
Immunity may be defined as the state of being able to 
resist and/or overcome harmful agents or influences (Weiser 
et al., 1969). The science of immunology encompasses a study 
of immunity and is a direct outgrowth of the study of host 
responses to infectious agents. In fact, the early successes 
of bacteriology are the foundations upon which modern im­
munology rests. At the present time, however, immunology 
has evolved as a true science and encompasses the study of 
immunologic mechanisms in relation to disease processes, in 
the causation of disease, and as an experimental method in 
association with other sciences. This treatise primarily re­
lates to a role for the immune processes in resisting bacterial 
infection. Therefore, the following discussion will be re­
stricted to mechanisms associated with resistance to infectious 
disease. 
Since late in the nineteenth century, there has been an 
understanding that both cellular and humoral factors are 
associated with resistance. Knowledge of the basic cellular 
mechanisms dates from the classical discovery of phagocytosis 
by Metchnikoff (Hirsch, 1965) and the description of the 
delayed-hypersensitivity reaction by Koch (Weiser et , 
1969) . Knowledge of the involvement of humoral factors dates 
from the work of Buchner, von Behring, Erhlich and others 
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around 1890 (Weiser et , 1969) . Primary emphasis during 
the early twentieth century was on humoral factors. This 
restriction of interest was due to a primary concern with 
the protective role of serum antibody, particularly as related 
to antitoxic immunity. Also, the discovery of complement 
by Bordet in 1899 (Bordet, 1899) strengthened the concept 
of humoral protective factors in immunity. 
It is now known, however, that cellular mechanisms are 
also involved in the immune response to infectious agents and 
these play perhaps the most critical and decisive role in 
certain host-parasite interactions. Thus, immunity must in­
clude a very broad biologic view encompassing the vast inter­
play of humoral and cellular factors which comprise the total 
immunologic responses of the host (Bellanti, 1971). The cel­
lular-humoral dichotomy is illustrated by the clinical obser­
vations of increased susceptibility to infection seen in 
individuals with congenital defects of the immunologic system 
(Good, 19 71). Some individuals lack the humoral protective 
function but retain the cellular; others are deficient in 
cellular but have normal humoral activity; still others are 
defective in both humoral and cellular functions. Clearly 
both areas are of profound importance and both cellular and 
humoral factors are interrelated and interdependent. 
With due recognition of the interrelationships, immunity 
will be categorized for purposes of discussion as (1) natural. 
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(2) acquired, (3) cell-mediated, and (4) humoral. 
Natural immunity 
The resistance which an individual possesses even before 
contact with a pathogenic organism is called innate or natural 
immunity and can involve cellular as well as humoral aspects. 
This form of immunity has a genetic basis and is subject to 
species and individual variation (Gowen, 1960). Many as­
pects of the functional basis for innate immunity are unknown; 
moreover, it is extremely difficult to distinguish between 
defense factors that represent innate and acquired immunity. 
As a consequence, although some of the mechanisms are recog­
nized, innate immunity is not well-defined and is difficult 
to accurately quantitate at the present time (Raffel, 1961). 
Acquired immunity 
Acquired immunity is the resistance which develops as a 
result of contact with the organism in question or is the 
result of transfer of immune substances from another individual. 
Acquired immunity tends to possess a degree of specificity not 
associated with natural immunity but may be either cellular 
or humoral in character. Specific immunity that is acquired 
actively by natural means usually develops as a result of 
either an apparent or inapparent encounter with a parasite or 
with related organisms. On the other hand, immunity that is 
acquired passively by natural means involves the transfer of 
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a specific immune globulin (antibody) from the mother to the 
fetus or neonate by way of the placenta or colostrum (Bram-
bell/ 1970). Apparently, acquired passive immunity in man 
is, for the most part, largely mediated by specific antibody 
of the class immunoglobulin-G because such immunity is trans­
ferred almost exclusively to the fetus by way of the pla­
centa. However, in other species of animals, including 
laboratory and domestic animals, antibody of various classes 
may be transferred via colostrum (Brambell, 1970). 
Immunity that is acquired actively by artificial means 
is the result of purposeful vaccination with immunogenic anti­
gen (s) derived from or associated with a specific microorgan­
ism. Immunity that is acquired passively by artificial means 
is accomplished by the injection of an immune serum which 
contains globulins capable of conveying specific immunity 
against a given microorganism. 
Cell-mediated immunity 
The term "cell-mediated immunity" will be used to 
describe those resistance mechanisms in which cells play a 
major role. This terminology is preferable to "cellular 
immunity" which according to Mackaness and Blanden "will be 
found written with quotation marks, as if to signify ambiguity 
or doubt in the mind of the author. There is reason for this, 
for the concept is vague, the underlying immunological 
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processes are ill-defined, and the term has been used with 
two different connotations" (Mackaness and Blanden, 1970). 
Cell-mediated immunity relates to the immunologic processes 
involving phagocytic cells and specifically sensitized 
lymphocytes. 
The phagocytic cells of the mammalian host comprise one 
of the very important defense mechanisms against invading 
microorganisms. Phagocytic cells are grouped into two basic 
classes: (a) polymorphonuclear phagocytes found in marrow, 
blood, and tissues, and (b) mononuclear phagocytes, including 
blood monocytes and macrophages of tissues and various organs 
such as the liver, spleen, lymph glands, and bone marrow 
(Hirsch, 1965). When invading microorganisms pass the natural 
barriers such as skin and mucous membranes, they may be acted 
upon by the defense mechanisms of phagocytosis and inflamma­
tion. In the tissues, polymorphonuclear neutrophils (PMNs) 
and macrophages attracted to the site by an inflammatory 
response may engulf and destroy the invading microorganisms. 
Foreign materials reaching the blood or lymphatic system are 
subsequently engulfed by PMNs or filtered out by phagocytic 
cells of the reticuloendothelial system (RES). The RES in­
volves cells of the spleen, thymus, liver and other lymphoid 
tissues and acts to remove effete and worn-out cells, to re­
move foreign materials, and probably plays a role in antibody 
formation, particularly in lymph nodes (Carpenter, 1965). 
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Phagocytosis is enhanced by other factors associated with 
the immunologic system such as antibody, complement and immuno-
conglutinin. Macrophages are able to interact with anti­
bodies which have an affinity for certain receptors on the 
membranes of these cells. This antibody is denoted as cyto-
philic for macrophages, because of its exceptionally strong 
affinity for their membranes (Berken and Benacerraf, 1966; 
Gordon and Ford, 1971). Macrophages containing cytophilic 
r-itibody have definitely enhanced abilities to recognize, 
engulf and destroy antigenic micro-organisms, or to restrict 
their intracellular growth (Gordon and Ford, 1971). 
Macrophages are also an important contributor to acquired 
resistance. With certain types of chronic bacterial infec­
tions , immune phagocytes develop which have an increased 
ability to engulf and destroy bacterial organisms (Fong et , 
1964; Elberg, 1960). This type of resistance is established 
only following contact with living bacterial organisms or as 
a result of experimental transfer of nucleic acid rich frac­
tions of immune macrophages (Fong et , 1964). 
Exemplifying one of the most notable features of acquired 
cellular resistance is the inactivation of S. typhimurium in 
the phagocytic cells of actively infected mice which commences 
almost immediately after ingestion and proceeds rapidly until 
virtually every intracellular organism has been killed. This 
microbicidal effect is not due to specific anti-bacterial 
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antibody because cells from animals infected with Listeria 
monocytogenes or S_. typhimurium are equally microbicidal for 
S^. typhimurium despite the absence of demonstrable anti-
Salmonella antibody either in the serum or adsorbed to the 
cells of the Listeria-infected mice (Mackaness, 1970; 
Mackanessj 1971b). 
Recently, the term "cellular immunity" has been applied 
to resistance phenomena associated with sensitized lympho­
cytes (Mackaness, 1970). The sensitized lymphocyte serves as 
a mediator of a number of reactions . These small-to-medium 
lymphocytes that have become sensitized to the antigen by 
previous exposure act to recognize the antigen. The molecular 
basis of antigen recognition by sensitized lymphocytes is 
not clearly understood but must be mediated by receptors on 
their surface (Bach al.-/ 1971). Classical immunoglobulins 
have not been demonstrated to have a role in this recognition, 
but nonetheless, cellular recognition of antigen is highly 
specific (Bach et aJ., 1971; Gordon and Ford, 1971). This 
type of immunity involves specifically sensitized lymphocytes 
and the mechanism appears to be monitored by the thymus and 
mediated by the thymic dependent group of lymphoreticular 
tissues (Bellanti, 1971). The sensitized lymphocyte serves 
as a mediating cell in immunologic responses such as enhanced 
phagocytosis, delayed hypersensitivity and the rejection of 
foreign grafts and malignant cells (Mackaness,1971a). Reaction 
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of a sensitized lymphocyte with its target antigen results 
in the activation of the sensitized cell, stimulating it to 
release substances which affect macrophages (Mackaness, 1971b). 
One of these substances is chemotactic for circulating blood 
monocytes, inducing these cells to emigrate through the walls 
of vessels and accumulate in the region of the activated 
lymphocyte, assuming the form of tissue macrophages or histio­
cytes. Another substance (macrophage inhibiting factor) re­
leased from activated lymphocytes inhibits the migration of 
macrophages in proximity to the lymphocyte, preventing these 
cells from leaving the site. Histological section of such 
sites, therefore, shows massive infiltration of mononuclear 
phagocytes. These macrophages are responsible for many of 
the features of cellular reactions (Mackaness, 1971b; Gordon 
and Ford, 1971; Nelson, 1969). 
Humoral immunity 
Resistance to disease processes or conditions can be 
mediated by a number of humoral factors either normally 
present in the animal body or produced by contact with or ex­
posure to antigen(s). These factors may act alone or common­
ly act in concert to establish or produce resistance to in­
fectious agents. Among the humoral resistance factors are 
included antibodies, complement, properdin, beta-lysin, 
lysozyme and immuno-conglutinin. 
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Antibodies An antibody is "a substance (commonly, 
if not always, a gamma globulin) which can be incited in an 
animal by an cintigen or by hapten combined with a carrier and 
which reacts specifically with the antigen or hapten. Some 
antibodies occur naturally without known antigen stimulation" 
(Weiser et 0^., 1969). Antibodies are a heterogeneous mixture 
of proteins found in the gamma and beta globulin fractions of 
serum. Antibodies occur as a variety of classes and sub­
classes of globulin molecules (immunoglobulins). Antibodies 
have been described in terms of some functional parameter of 
interaction with antigen as precipitins, lysihs, antitoxins, 
agglutinins and so on, and it was previously thought that 
these effects were due to the same kind of antibody acting 
in different circumstances (Humphrey, 1967). It is now clear 
that not all antibodies reacting with the same antigen are of 
the same kind; they may differ in function as well as in 
their biologic properties (Holborow, 1968; Raffel, 1961). 
Natural antibody Substances that react with an antigen 
may occur in the blood of animals which have not been immunized 
and, presumably, have had no contact with the antigen. Among 
these antigens are erythrocytes of different individuals. of 
the same species. These substances, very similar to induced 
antibodies in their behavior, are called natural or normal 
antibodies. Although some so-called normal antibodies can, in 
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fact, be accounted for by antigenic stimulation, the presence 
of many natural antibodies cannot be satisfactorily explained 
at the present time. 
A prime example of a class of normal antibodies is the 
isoagglutinins of the human blood groups (Race and Sanger, 
1962). Although the presence or absence of these antibodies 
is genetically dependent, their mode of origin is still con­
troversial (Wiener, 1951; Abramoff and La Via, 1970). Anti­
bodies to certain bacteria have been demonstrated without 
apparent antigenic stimulation (Boyden, 1966; Skarnes and 
Watson, 1957; Shilo, 1959). Jerne (1956) described natural 
antibodies against bacteriophages; however, the most ex­
tensively studied natural antibodies have been those reactive 
with pathogenic bacteria and those responsible for blood group 
incompatibility (Wilson and Miles, 1955; Skames and Watson, 
1957). When present in serum, natural antibodies are low in 
titer, but they may exercise a significant role in conferring 
resistance to certain infections. 
Acquired antibody Acquired antibodies are specific 
globulins produced by the body in response to contact with an 
antigen (Raffel, 1961; Carpenter, 1965). Encounter with an 
antigen leads to a series of metabolic and cellular phenomena 
culminating in the elaboration of antibody molecules capable 
of reacting with the antigen. 
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The mechanism of antibody formation has been a subject 
for extensive study in recent years, but all aspects have not 
been clearly elucidated. It is apparent that synthesis of 
specific antibody takes place in lymphocytes and plasma cells 
(Henriksen, 1970). These specialized cells of the lympho-
reticular tissues synthesize gamma globulins in their ribo-
somes located on the endoplasmic reticulum of the cytoplasm 
(Carpenter, 1965). Therefore, actual synthesis of antibody 
does not differ from the normal protein synthesizing process 
in mammalian cells. However, the inductive phase, or the 
mechanism whereby cells are stimulated to elaborate a highly 
specific protein molecule, is not clearly understood. Anti­
gen in some manner induces cells of the lymphoid system to 
differentiate and multiply so that variable quantities of 
antibody may be produced. 
The manner of presentation of antigen.appears to be 
critical in antibody formation; some antigens apparently re­
quire processing by macrophages and a subsequent transfer of 
information to antibody producing cells (Henriksen, 1970). 
Other antigens act directly on receptor sites located on the 
surface of immunocompetent lymphocytes to trigger the process 
of antibody formation (Mackaness, 1971a) . Antibody formation 
is, therefore, an extremely complex process involving not only 
cell cooperation phenomena, but also the biochemical phenomena 
associated with antigen metabolism and protein synthesis. 
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Complement The term complement refers to a collective 
group of eleven blood serum proteins normally present in the 
blood of vertebrate species. The proteins are regarded 
operationally as a biological system that engages in a char­
acteristic series of reactions in the presence of antigen-
antibody complexes (Muller-Eberhard, 1969a). Complement is 
commonly defined on the basis of its membrane-damaging or 
cytolytic activity since the occurrence of the reaction termed 
"fixation" in the immediate vicinity of biological membranes 
may lead to destruction of the membrane. However, complement 
is now known to participate in a variety of immunologic and 
pathologic reactions (Muller-Eberhard, 1969b). 
The presence of complement in fresh normal serum and its 
vibriolytic activity was initially observed by Bordet (Bordet, 
1899). Complement has subsequently been shown to be a normal 
constituent of serum and to be globulin in character but un­
related to immunoglobulins. The concentration of complement 
in serum is rather constant for each species of animal, al­
though its level may increase or decrease in certain disease 
states. In man, complement is present at birth, although in 
lower concentration than in the adult (Lepow, 1965). Its 
concentration is not influenced by immunization. 
Since its discovery, the cytolytic activity of serum has 
been dissected into a growing number of components until its 
full complexity emerged (Muller-Eberhard, 196 8). It is now 
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known ^hat eleven distinct serum factors act in concert to 
generate the cytolytic activity of the complement system. 
According to a consensus of the active workers in the comple­
ment field/ the components of complement (C) are designated 
by numerals/ i.-e-/ they are referred to as C'l, C'2, C'3/ 
C'4/ C'5/ C*6/ C'7/ C*8/ and C'9; and the three subcomponents 
of C'l are called C'lg, C'lr, and C'ls. Each component is. 
defined by its position in the complement reaction sequence 
and also by physical and chemical characteristics. Most 
importantly/ it is now possible to define complement components 
in terms of their unique immunochemical properties, since 
specific antisera have been prepared to at least six of them. 
In addition to causing membrane damage, complement has 
other biologic effects which may play a role in host defense 
to infections and in mechanisms of inflammation. Thus, comple­
ment and its components are involved in the potentiation of 
phagocytosis, opsonification, immune adherence, increased 
vascular permeability due to anaphylatoxin and histamine re­
lease, and white cell chemotaxis (Gerwurz, 1971; Muller-
Eberhard, 1968; Jensen, 1967). 
Properdin Studies by Pillemer and co-workers/ (1953a) 
on the mechanism of inactivation of the third component of 
human complement by zymosan led directly to discovery of a 
previously unrecognized serum protein, properdin, and to the 
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concept of the properdin system. It had been known since 
the early work of von Dungern (1900) that whole yeast cells 
inactivate C'3. Later investigations by Whitehead, Gordon 
and Wormall (1925) showed that a fraction of yeast, called 
zymin, could be substituted for whole yeast cells. Subse­
quently, Pillemer and Ecker (1941) isolated a yeast product, 
zymosan, which was derived from the cell wall of yeast, was 
mainly carbohydrate in nature, and was highly active in inacti­
vating C*3 at 37°C. It was generally assumed that C'3 was 
adsorbed to the surface of zymosan, a product insoluble in 
aqueous media, but detailed investigations had not been per­
formed. Subsequent studies revealed that inactivation of C'3 
by zymosan was not a simple adsorption but had kinetic charac­
teristics both of a stoichiometric and an enzymatic reaction 
(Pillemer et , 1953b). Furthermore, they demonstrated that 
Mg++, a hydrazine-sensitive serum factor resembling C'4, and 
a heat-labile serum factor resembling C'l or C'2 were all 
required for inactivation of C'3 by zymosan. The reaction 
was further dependent on pH, ionic strength, temperature and 
time. 
Detailed investigation of the effect of temperature on 
inactivation of C'3 by zymosan made possible the discovery of 
properdin (Pillemer et a^., 1954). Although zymosan did not 
inactivate C'3 in human serum at 15°C, C'3 in the resulting 
supernatant serum could not be inactivated by fresh zymosan at 
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37°C. Adsorption of a normal serum protein, properdin, by 
zymosan at 15°C was demonstrated. This substance could be 
eluted from the zymosan complex formed at 15°C. Addition of 
the eluate to serum adsorbed with zymosan at 15°C and, there­
fore, deficient in properdin reconstituted a complete system 
for inactivation of C'3 by fresh zymosan at 37°C. Properdin 
was, therefore, defined i,. terms of its requirement for in­
activation of C'3 by zymosan. Serum lacking properdin (RP) 
was assumed to supply in excess all of the other factors re­
quired for inactivation of C'3, including Mg++ and the 
hydrazine-labile and heat-labile serum constituents. All of 
these factors considered as a group were termed the properdin 
system. 
Properdin itself was partially purified by adsorption to 
and elution from zymosan under optimal conditions (Todd ejt aJ. , 
1959). Preparations purified 2500-fold with respect to serum 
were subjected to chemical, physico-chemical, biological and 
immunological characterization (Lepow et a^., 1959). The 
absorption spectrum exhibited a typical protein absorption 
maximum at 2 80 my. At a concentration of 600 units of 
properdin per ml, small amounts of glucose (after acid hydro­
lysis) and lipid but no phosphorus were detectable. Electro-
phoretic analysis in pH 8.6 barbital buffer showed a major 
peak (90%) with the mobility of gamma 1-globulins and a second 
peak (10%) corresponding to gamma 2-globulins. Analysis in 
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the ultracentrifuge revealed four components with sedimenta­
tion constants of about 6, 9, 12 and 18S. Properdin activity 
was associated primarily with the fastest sedimenting 
component. 
Ouchterlony analysis, using rabbit antiserum to partially 
purified human properdin, showed the presence of at least five 
antigens. After absorption of the rabbit antiserum with human 
RP, a single line was observed, probably representing proper­
din. A variety of trace activities was found in partially 
purified properdin, including anti-A and anti-B isohemagglu-
tinins, an agglutinin for zymosan, several blood clotting 
factors, lysozyme and phosphatase. All of these could be 
shown, however, to be distinct from properdin itself (Lepow 
et al. , 1959) . 
Despite the heterogeneity of partially purified properdin, 
the preparation displayed common activity in a variety of 
biological systems. Human serum deficient in properdin (HP) 
was not only altered with respect to inactivation of C'3 
by zymosan at 37°C but was also inactive or greatly reduced 
in activity with respect to certain bactericidal, virus-
neutralizing, hemolytic and protozoa-inactivating properties 
of the parent serum. These activities could be restored to 
RP by addition of small amounts of partially purified human 
properdin. These observations strengthened the original con­
cept of the properdin system and led to the hypothesis that 
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the properdin system was a nonspecific humoral mechanism which 
might be part of the host's defenses in natural resistance. 
Properdin biologically functions in the bactericidal activity 
of normal serum against a variety of gram-negative bacteria 
(Wardlaw and Pillemer, 1956), the neutralizing activity of 
normal serum for certain viruses (Wedgwood et , 1956), the 
hemolytic activity of normal serum against erythrocytes from 
patients with nocturnal hemoglobinuria (Hinz et , 1956) 
and against erythrocytes treated with tannic acid (Hinz et , 
1957)- The functional role of properdin is undoubtedly 
associated with the fixation of complement and recent ex­
perimentation permitted Lepow (1971) to conclude "there can 
no longer be reasonable doubt about the properdin system as a 
unique, alternative pathway to the terminal components of 
complement. It therefore comprises an additional mechanism 
for generating biologically active, complement-derived cleavage 
products, as well as mediating certain bactericidal, virus -
neutralizing, and hemolytic properties of normal serum." 
Beta-lysin Beta-lysin is an enzyme which is active 
against gram-positive bacterial organisms (Skarnes and Watson, 
1957). Beta-lysin is usually present in low levels in normal 
human serum and appears in greatly increased amounts during 
the acute phase of infectious and other inflammatory diseases 
(Weiser et al., 1969). The source of the material has been 
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reported to be platelets and is distinct from lysozyme, 
complement, and antibody. It appears to be a complex system 
of enzymes which are very effective bactericidal agents 
(Donaldson et , 1964) . 
Lysozyme Lysozyme is a mucolytic enzyme which has 
been shown to have bactericidal activity. This enzyme is 
found abundantly in phagocytic cells but also in body fluids 
(Heise and Myrvik, 1967). The enzyme functions by virtue of 
mucolytic properties which cleave acetyl-amino-sugars, the 
structural backbone of both gram-positive and gram-negative 
bacteria. This material appears to be an important non­
specific defense mechanism of the host, may function inde­
pendently and is known to accentuate the cytolytic activity 
of complement (Weiser, et , 1969). 
Immuno-conglutinin Immuno-conglutinin is a nonspeci­
fic humoral substance occurring in many animals, including 
rabbits, guinea pigs, mice, cats and man, as a result of in­
fection with bacteria, viruses, rickettsia, and protozoa 
(Coombs et a^., 1961). The time of increase and peak titer 
correspond well with the specific antibody response. In 
acute infections the titer slowly declines to pre-infection 
levels in 30 days. In chronic infections the titer may per­
sist. In mice, production of immuno-conglutinin has been 
demonstrated as a result of subclinical infection (Ingram, 
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1959). Immuno-conglutinins are auto-antibodies against certain 
components of complement which often appear in the sera of 
human beings in whom massive antigen-antibody reactions are 
taking place. The functional significance of immuno-conglutin-
in is in the enhancement of phagocytosis (Weiser e^ , 1969) . 
Biological amplification 
The interaction of humoral and cellular factors repre­
sents a group of phenomena termed biologic amplification 
systems (Good e^ al., 1970). While a single mechanism of 
resistance may function to some degree in combating an in­
fectious process, the synergistic effect of multiple factors 
may greatly augment the reaction. Representative of such 
reactions are the combined cytolytic effects of complement and 
lysozyme, the enhanced phagocytic activity in the presence of 
antibody, the further enhancement of phagocytosis in the 
presence of antibody, complement and immuno-conglutinins and 
the participation of a variety of factors in the inflammatory 
response. 
Inflammation is a classical example of participation by 
multiple cellular and humoral factors. Antibody may complex 
with an invading microorganism; complement is fixed; fixation 
of complement leads to release of chemotactic factors (which 
attract macrophages) or anaphylatoxin (which increases vascular 
permeability); additional quantities of complement may lead to 
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bacteriolytic and bactericidal activity; attracted macro­
phages may engulf and destroy the microorganisms; macrophages 
may release lysozyme which is bacteriolytic; sensitized lymph­
ocytes may release macrophage inhibiting factor to retain 
macrophages in the area; sensitized lymphocytes may transfer 
information to macrophages to enhance the phagocytic and 
microbicidal activities. This interplay between complement 
and other factors is the mechanistic basis for the inflamma­
tory response. 
The kallikrein system is yet another component of the 
amplification system and represents a well defined system of 
proteins in plasma, activated by a reaction of antigen with 
antibody. Presumably, the enzyme kallikrein interacts with 
its substrate to produce several vasoactive peptides; slow 
reactive substance and anaphylatoxin are humoral factors 
generated by the interaction of antigen with sensitized cells. 
All of these agents increase capillary permeabiltiy (Bellanti, 
1971). 
Factors influencing immunity 
Genetic considerations The host-parasite relationship 
may be influenced by mechanisms which are genetically con­
trolled. Genetic variations in the host as well as in the 
parasite are important factors in this relationship. In 
species where variations of resistance exist, individual dif­
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ferences may be found which depend on genetic factors. Rich 
(1923) established a strain of guinea pigs deficient for 
complement. Later studies suggested that the deficiency was 
due to lack of the third component of complement (C'3) (Hyde, 
1923). This strain was distinct from normal guinea pigs which 
possess relatively high levels of all components of complement. 
Genetic analysis indicated that the deficiency depended on 
the homozygous condition of the recessive allele of a single 
gene. Mortality in the complement deficient guinea pigs 
was significantly higher following infection by certain patho­
gens (Rich/ 1923; Hyde, 1923). 
Variations of genotype in mice permits separation of 
strains which are resistant, susceptible, or of intermediate 
resistance to infection by S. typhimurium. Gowen (1960) 
found that the response of these mice to typhoid infection 
was an inherited characteristic and could not be attributed 
to acquired immunity. The experiments further suggested 
that response to immunization with heat killed S. typhimurium 
resulted in lOO- to 200-fold increase of resistance in 
these strains. The relative differences of resistance, after 
vaccination, however, remained unchanged, paralleling those 
found in the natural resistance and dependent on the genotype 
of the host. 
Lurie and co-workers (1952) demonstrated in inbred rabbit 
strains varying resistance to infection by bovine or human 
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tubercle bacilli, which was genetically controlled. The ac­
quired resistance that followed infection or immunization with 
attenuated tubercle bacilli was greater in the strains which 
possessed natural resistance than that in the susceptible 
strains. The determinants of natural resistance were found to 
be multiple, complex and additive in nature. 
In man, susceptibility to certain infectious agents 
may be attributable to genetic factors. Congenital agamma­
globulinemia is a hereditary disorder occurring predominantly 
in male children and usually transmitted as a sex-linked 
recessive characteristic (Gitlin, Janeway, Apt, and Craig, 
1959) . (The deficiency in plasma globulins in this disease 
is due to an almost complete failure to synthesize gamma­
globulins and respond with production of specific antibodies 
after infection or antigenic stimulation.) (The affected 
individuals have very low resistance to infections caused by 
gram-positive bacteria but are not unusually susceptible to 
infections caused by gram-negative organisms and seem to have, 
to some degree, the ability to develop immunity to certain 
viral diseases.) Isohemagglutinins are generally absent or 
present in very low titer. Despite the deficiency in gamma­
globulins and antibodies in this disorder, hypersensitivity 
reactions of the delayed type are not infrequent and may be 
artificially induced (Porter, 1956) . 
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Nutrition Malnutrition may cause a reduction of re­
sistance to infection. In general, susceptibility to infec­
tion may depend on the physiologic condition of the host. 
Helweg-Larsen and co-workers (1952) gave an account of health 
problems which affected internees in German concentration 
camps. Among the infectious disease most frequently occurring 
were the ones caused by microorganisms endemic in the normal 
European communities. Exotic, unusual epidemices like typhus, 
cholera or even bacillary dysentery were uncommon. In the 
opinion of the authors, increase in person-to-person contact 
could hardly account for the aggravation of these endemic 
diseases. The loss of natural resistance caused by malnu­
trition and other forms of physiologic misery seemed far more 
important. Most of the internees overcame disease due to 
microbial origin shortly after return to normal environment 
and frequently without the help of specific therapy. In the 
case of tuberculosis, rapid recovery usually occurred, even 
though no antimicrobial agent was available for its treat­
ment. 
It has been shown in experiments with exactly-defined 
diets that pantothenic acid deficiency can evoke latent 
Corynebacteria infections and also render normal animals 
more susceptible to experimental infection with these micro­
organisms (Zucker and Zucker, 1954). Axelrod and Pruzanski 
(1955) induced pantothenic acid or pyridoxine deficiency in 
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rats by feeding them specialized diets. The experiments 
demonstrated a marked impairmp-t of ability of these rats 
to produce antibodies to a soluble protein antigen, diphtheria 
toxoid/ or to a cellular antigen, sheep erythrocytes. 
Physical and chemical Antibody formation and other 
forms of immune response can be affected by a number of 
physical and chemical factors. The effects of such factors 
on the different phases of the immune response are not all the 
same (Henriksen, 1970). 
Roentgen rays and other ionizing radiation are active 
factors. High doses of whole body irradiation can abolish 
all immunologic responsiveness in an animal. Radiation in­
hibits antibody synthesis by destruction of small lympho­
cytes, and its mechanism is undoubtedly the depletion of these 
radio-sensitive cells (Schwartz, 1971). Also, cortisone and 
related corticosteroids reduce antibody formation by selective­
ly suppressing small lymphocytes and eosinophils (Henriksen, 
1970). 
Other immunosuppressive substances include: (1) alkyla-
ting-agents whose effect resembles that of radiation, ^.e., 
denaturation of protein and DNA, (2) purine analogues, which 
block interconversion of nucleotides and disturb DNA synthesis, 
(3) pyrimidine analogues whose incorporation into DNA 
renders it nonfunctional and incapable of mitosis, and (4) 
folic acid analogues which prevent transformation of folic 
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acid to folinic acid and thereby prevents the biosynthesis of 
purines, pyrimidines and certain amino acids (Henriksen, 1970).. 
As with all physiologic mechanisms, the immunologic 
response may be viewed as an adaptive system in which the 
body attempts to maintain homeostasis of the internal body 
environment with the external environment. 
Following confrontation of the host with a foreign 
stimulus (antigen), there is a period of dysequilibrium. 
Immunologic balance is then restored by an appropriate immuno­
logic response. A perturbation occurs if the stimulus and the 
response are inappropriate to each other. Any derangement 
in homeostasis would result in production of undesirable 
sequelae thus interfering with immunologic responses. 
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OBJECTIVES 
The objectives of the experimentation outlined in this 
dissertation were: (1) to determine the amounts of lead that 
produce subclinical effects in mice when injected in soluble 
form (2) to determine the effect of this heavy metal on re­
sistance of mice to infectious disease and (3) to determine 
immunologic mechanisms whereby lead increases the suscepti­
bility of mice to bacterial infection. 
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MATERIALS AND METHODS 
Experimental Animals 
Young adult female white mice (Swiss-Webster strain) were 
used in all experiments. The mice were of uniform size and 
age, weighing 18-20 grains and were procured from a commercial 
source.^ Approximately 1,200 mice were used in the experi­
mentation described herein. Five mice were held in each poly-
2 
carbonate cage. They were fed Purina Laboratory Chow and 
received water a^ libitum. 
Lead Compounds 
Reagent grade lead nitrate crystals were purchased from 
a commercial source.^ Lead stock solutions for injection were 
prepared by dissolving 50 mg of PbCNO^jg in 50 ml of sterile 
normal saline solution (0.85% NaCl) (NSS). Twenty parts of 
the soluble lead stock solution were then mixed with 80 parts 
of NSS to prepare a 100 yg lead concentration in a 0.5 ml 
volume. A 250 yg lead concentration in each 0.5 ml volume 
was prepared similarly by mixing equal volumes of the lead 
stock solution and NSS. The lead solutions were sterilized 
by autoclaving for 10 minutes at a temperature of 240*F. and 
^Midwest Animal Colony, Corning, Iowa. 
2 Ralston Purina Company, Brunswick, New Jersey. 
^Allied Chemical, General Division, Morristown. New 
Jersey. 
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allowed to cool at room temperature prior to injection. 
Lead Treatment of Mice 
The mice used in these experiments were given daily 
intraperitoneal injections of either soluble lead nitrate, 
sodium nitrate, or NSS for 28 to 30 days. Lead solutions, 
as prepared above, had been previously given to normal mice 
for 30 consecutive days. No signs of clinical toxicity were 
observed in the groups of mice receiving lead as compared to 
control animals which received only sterile NSS. The injec­
tions of lead solutions and NSS were given in 0.5 ml amounts. 
Collection and Storage of 
Mouse Sera 
Blood from the lead-treated and control mice was col­
lected either by decapitation of the animals or by obtaining 
a specimen of blood from the periorbital sinus using 100 
lamba disposable capillary pipettes. In the latter technique, 
one-tenth milliliter aliguots of blood were mixed with 0.4 ml 
of NSS and allowed to clot. The diluted blood was centrifuged 
at 1500 g for 10 minutes and the supernatant fluid containing 
the serum was recovered. The dilution of serum was considered 
to be approximately 1:5. 
In the former technique, lead-treated and control mice 
were anesthetized with ether and exsanguinated by decapitation. 
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Generally, 0.5 to 0.8 ml of blood was obtained from each ani­
mal and allowed to clot in 60 x 15 mm plastic petri dishes.^ 
For some experiments, blood from a g. oup c mice was pooled 
to yield a single serum specimen. The seva were processed 
and collected as described above. All sera were placed in 
one-dram screw-cap vials, promptly frozen and stored at -70°C. 
until used. 
Bacterial Cultures 
Salmonella typhimurium var. Copenhagen (§_. typhimurium) 
was the organism used throughout this study. The culture was 
obtained from J. A. Christopher, Department of Bacteriology, 
Iowa State University, Ames, Iowa. Typing and identifica­
tion of the organism was originally performed at the National 
Center for Disease Control, Atlanta, Georgia. The initial 
culture was taken from a nutrient agar slant maintained at 
4®C, and all further cultures used were made from slant 
cultures of the original. This strain produced acid and gas 
from glucose, maltose, sorbitol, xylose, rhamnose, inositol 
and trehalose, but did not ferment lactose, sucrose or 
salicin. Hydrogen sulfide was produced but urea was not 
hydrolyzed and indole was not produced. The bacterial agent 
was cultured in 4 ml of trypticase soy broth for 24 hours 
^Falcon Plastics, Div. Becton, Dickinson and Co., Oxnard, 
California. 
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at 37®C. Following the 24-hour incubation period, a standard­
ized quantity of the culture was transferred to 4 ml of fresh 
trypticase soy broth and incubated at 37°C for an additional 
4 hours. To check for contamination and/or mutations, colonies 
of the organism were routinely grown on blood agar, brilliant 
green and tergitoi agar plates at 37°C for 24 hours. Figure 1 
depicts characteristics of a 4-hour bacterial culture of S^. 
typhimurium. 
Viable Cell Count of 
S. typhiumurium 
The viable cell population was determined using the pour 
plate method. The 4-hour cultures were diluted by 5-fold 
serial dilutions in sterile saline dilution blanks. Five-
tenths milliliter of each dilution was pipetted into duplicate 
sterile plastic petri plates and mixed with approximately 15 
ml of sterile melted plate count agar.^ The plates were 
rotated gently to spread the bacterial cells, thus allowing 
even distribution of the bacterial suspension throughout the 
agar. The agar was allowed to solidify at room temperature, 
and the plates were incubated in an inverted position at 37°C. 
After 24 hours, bacterial colonies were counted and counts 
were averaged for each duplicate plating. The total number 
of organisms was determined by multiplying the number of 
^Difco Laboratories, Inc., Detroit, Michigan. 
Figure 1. Photographs showing characteristics of bacterial 
culture of S. typhimurium var. Copenhagen 
upper left - colonies of 24-hour growth on blood 
agar 
upper right- colonies of 24-hour growth on bril­
liant green agar 
lower left - colonies of 24-hour growth on 
tergitol agar 
lower right- specific Salmonella fluorescent anti­
body stain of the bacterial organism 
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colonies counted by the appropriate dilution factor. 
LD^Q Titration of 
S. typhimurium 
A 4-hour culture of typhimurium was grown in trypti-
case soy broth as previously described. Five-fold serial 
dilutions of the undiluted culture were made in sterile saline 
dilution blanks. A total of five dilutions were used corre­
sponding to 10 10 10 10 and 10 ^. Previous 
titrations of the agent indicated that a 4-hour culture con-
g 
tained approximately 10 organisms per ml as determined by 
plate counts. Five mice per dilution were inoculated intra-
peritoneally with 0.5 ml of the bacterial suspension. The 
death rate of the mice was monitored for 20 days. The 
of the 4-hour culture for normal mice was determined to be 
— 3 7 10 * as calculated by the method of Reed and Meunch (1938). 
Bacterial Agglutination 
Test 
The antibody titer of each mouse serum was determined 
by the microtiter tube agglutination test of Takatsy (1955) 
In microtiter agglutination plates.^ The reaction involved 
direct agglutination of thrice-washed formalin-killed £. 
typhimurium cells by the specific antibody. Reagents 
^Cooke Engineering Co., Alexandria, Va. 
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used in the test were 0.85% NaCl solution, 0.1% safranin dye 
solution, formalin-killed S. typhimurium cells and mouse anti-
S. typhimurium serum. The bacterial cells were grown in 
gauze-stoppered and paper-taped sterilized Ehrlenmeyer flasks 
containing 2 liters of sterile trypticase soy broth. They 
were incubated for 72 hours at 37®C with continuous moderate 
shaking on a variable speed rotator.^ Following the incuba­
tion period, the cells were chemically killed by adding to 
2 
each flask a volume of commercial formaldehyde solution to 
give a final concentration of 0.35% formaldehyde. Bactério­
logie assays were performed by streaking a sample of the 
formalin-treated cells on blood agar plates, brilliant green 
agar and tergitol plates at 24 and 48 hours after the addition 
of formalin. Sterility tests were also made by transferring 
a drop of the bacterial cell suspension into thioglycollate 
broth and incubating for 3-5 days at 37®C. The formalin-
killed bacterial cell suspensions were transferred to 250-ml 
screw-capped centrifuge bottles and sedimented by centrifu-
gation at 1500 g for 60 minutes in an International Centrifuge, 
Model UV.^ The sedimented cells were resuspended in NSS, 
transferred to 50-ml screw-capped centrifuge tubes and then 
washed five times with 40 ml of NSS each time. The cells were 
^Clay-Adams, Inc., New York, N.Y. 
2 Matheson, Coleman and Bell, Inc., Norwood, Ohio. 
^International Equipment Co., Needham Heights, Mass. 
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stored at 4°C and were always thrice-washed with NSS just 
prior to use in the agglutination test. Standardization of 
the bacterial suspension for use in the agglutination test was 
made by transferring a volume (0.15 ml) of packed cells to a 
tube and diluting with sterile NSS to a density equal to tube 
4 of a McFarland nephelometer (1200 x 10^ bacterial cells) . 
Enhanced visibility of the agglutination reaction was ac­
complished by staining the standardized suspension of bac­
terial cells with 0.1 ml of a 0.5% solution of Safranin 0 
dye. The dye was added directly to a tube containing 20 ml 
of suspended cells. The tube was shaken/ then incubated in 
a water bath at 37°C for 10 minutes. The stained cells were 
sedimented by centrifugation at 2000 g. They were next 
washed in NSS and then resuspended to their original volume 
in NSS. 
Serial two-fold dilutions of the mouse serums in NSS 
diluent were made in microtiter plates containing 0.05 ml 
of diluent. The diluted serum, processed as described above, 
was added to the first tube without further dilution. The 
starting dilution was considered to be 1:5. To each tube 
containing 0.05 ml of the serum dilution, a drop (0.05 ml) of 
safranin-stained phenol-killed S. typhimurium cell suspension 
was added. Control tubes containing only the saline diluent 
plus the safranin-stained cells were included. Other controls 
consisting of a high-titer rabbit anti-S. typhimurium serum 
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and a normal nonimmune mouse serum were also included with 
each test as a known positive and a known negative control 
respectively. The plates were shaken to disperse the cells 
and left undisturbed at room temperature for 8 to 12 hours. 
A positive reaction consisted of a layer of uniformly agglu­
tinated cells covering the bottom of the tubes. In a nega­
tive test, the bacterial cells were massed as a discreet 
button or a smooth ring at the bottom of the tubes. Partial 
agglutination was characterized by a smooth matting of cells 
with irregular edges. The highest serum dilution with com­
plete or partial agglutination was considered the end point. 
The agglutination titer was expressed as the number of the 
end point tube in the series of dilutions. 
Serum Protein Determination by Cellulose 
Acetate Electrophoresis 
To ascertain the effect of lead on serum protein compo­
nents, individual serum specimens corresponding to bleeding 
dates of 0, 4, 8, 12, 16, 20, 24 and 28 days were prepared 
for analysis by cellulose acetate electrophoresis. Total 
protein determinations were made of each serum sample by ap­
plying a drop (0.05 ml) of serum directly onto the glass 
window of a refractometer^ equipped with a scale for 
^T. S. Meter, American Optical, Buffalo, N.Y. 
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calibrating the total quantity of serum protein in grams/100 
ml. The separation of serum protein was carried out uiiing 
the Beckman microzone electrophoresis system^ and accessory 
kit. The accessory kit contained blotters, Spinco B2 veronal 
buffer, interconnecting cable, electrophoresis membranes, 
fixative-dye solution, glass drying plate, plastic envelopes, 
sample applicator, sample covers, squeegee, 5 trays and covers 
and a wash bottle. 
The cellulose acetate membranes were soaked with the 
buffer solution (pH 8.6; y=0.075) by careful flotation fol­
lowed by immersing the membranes completely to avoid trapped 
air bubbles which produce dry spots on the membrane thus 
interfering with the electrophoretic pattern. The membranes 
were lightly blotted between two paper blotters to eliminate 
excess moisture or fluid droplets. The membrane was next 
positioned on the connecting bars of the microzone cell in 
such a way that the edges of the membrane were evenly de­
ployed within the veronal buffer filling the chambers of the 
cell. The cellulose acetate membranes accommodated 8 serum 
samples per run and the samples were applied by use of a 
wire applicator calibrated to deliver about 1.0 to 1.5 lambda 
of the sample. After checking the anode and cathode connec­
tions, the top of the apparatus was put in place and the serums 
1 
Beckman Instruments, Inc., Fullerton, Calif. 
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were electrophoresed for 60 minutes at a constant current 
of 15 milliamperes and a constant voltage of 250 volts. The 
separated serum protein zones were stained by immersing the 
membrane (for 3-5 minutes) in a solution of Ponceau S stain 
(0.2%) in 7.5% aqueous trichloroacetic acid and 7.5% sulfo-
salicylic acid. Rinsing of the cellulose acetate membranes 
was performed by removing the membrane from the stain with 
forceps to allow excess stain to drain away and then im­
mersing the membranes in several rinses of 5% acetic acid for 
1 minute each. After staining and rinsing, the cellulose 
acetate membranes were cleared by dehydrating in 95% ethanol 
for 1 minute, followed by immersion for 3 minutes in a clear­
ing fluid consisting of 10% acetic acid in 95% ethanol. The 
wet membrane was positioned onto a glass plate which had been 
previously placed in the bottom of the clearing solution tray. 
The glass plate and membrane were removed together from the 
clearing tray. Excess moisture was removed by gently but 
firmly drawing a squeegee over the full surface of the mem­
brane. The membrane and glass plate were dried in an oven 
preheated to about 65°C for 30 minutes. When the membrane 
was completely dried, it could be easily lifted from the 
glass plate and fixed between transparent plastic sealing 
sheets (envelopes) which were provided in the microzone 
accessory kit. The fixed membranes could be scanned im­
mediately or permanently stored in envelopes for later 
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scanning. 
Quantitation of the relative serum protein concentra­
tions from the stained cellulose acetate membranes was ac-
R 
complished by densitometry. A Gelscan automatic recording 
and integrating scanner^ was used in these studies to measure 
the light absorption by the stained bands of protein. Serum 
protein peaks were separated corresponding to albumin, alphas-
globulin, alphas-globulin, beta-globulin and gamma-globulin. 
Automatic continuous recording of the optical density (O.D.) 
and continuous integration of the area under the recorded 
curve of the O.D. were used in calculating the percent of the 
total protein corresponding to each separate peak. 
Whole Body Determination of 
Lead in Mice 
Lead-treated and nonlead-treated (control) mice were 
used in this experiment. The mice of each treatment group 
received daily intraperitoneal injections of either lOO ug or 
250 yg of lead nitrate for a total of 28 days. At four-day 
intervals, 2 mice of each treatment group and 1 mouse from 
the control group were euthanized and weighed on an analytical 
2 balance. Each mouse was placed into a Sorvall blender con-
^Gelman Instrument Co., Grand Prairie, Texas. 
2 Ivan Sorvall, Inc., Norwaik, Conn. 
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taining 20-30 ml water and 20 mg magnesium acetate per gram 
of mouse (magnesium acetate is used as a catalyst). After 
blending, the contents were quantitatively transferred into 
a porcelain crucible. The crucible was placed on a steam 
bath until the contents became well dried, usually over­
night. The crucible was then placed into a muffle furnace at 
a temperature of 450-475°C. At this temperature the sample 
was ashed within a period of 4-5 hours. When the crucible 
had cooled, the ash was dissolved in 2.0 N HCl, quantitative­
ly transferred, and diluted to a 100 ml volume in a volumetric 
flask. A lO-ml aliquot of the sample was placed in a sepa­
rate ry funnel and the pH adjusted to 6.5-7 with NaOH. One 
milliliter of ammonium pyrolidine dithiocarbamate was added, 
and the sample was shaken for 1 minute. Five to 10 ml of 
methyl isobutyl ketone (MIBK) was added, and the sample was 
again shaken for 2 minutes. The two layers were allowed to 
separate and the aqueous layer discarded. The MIBK layer was 
transferred to a centrifuge tube and centrifuged at 1500 x 
g for 10 minutes. Disposable pipettes were used to transfer 
the MIBK to a clean tube. A blank and standards ramging from 
0.2-2.0 parts per million (ppm) lead were extracted in a 
manner similar to the samples. A Perkin-Elmer Model 303 
atomic absorption spectrophotometer^ was used in the assay. 
^Perkin-Elmer Corp., Norwalk, Conn. 
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The wavelength (2833A), slit width, and lamp current were 
those specified as standard conditions. The burner head was 
adjusted until the top of the burner was approximately 1/4-
3/8 inch below the light path at the center of the burner. 
The burner was lit under normal flow conditions of air and 
acetylene. Water-saturated MIBK was aspirated and the 
acetylene flow set at 3.5 to 4.0 on the flow meter. The 
absorbance of the standards and samples was read using either 
the mil meter or a recorder. 
Histopathology of Lead-Treated 
and Control Mice 
Two mice from each of the 3 groups were killed every 4 
days over a period of 28 days. Organs surgically removed for 
histologic examination included liver, spleen, kidney and 
brain. Each organ was weighed on an analytical balance and 
the weights were recorded corresponding to the animal from 
whence they came. The organs of each animal were kept to­
gether and placed in jars containing 10% buffered formalin 
for 48 hours. After the 48-hour fixation period, the organs 
were removed from formalin and transferred to jars containing 
70% alcohol and stored under refrigeration at 4®C until they 
were paraffin embedded, sectioned and stained with hematoxylin 
and eosin (H & E). 
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Hematology 
Blood samples were collected from the periorbital sinuses 
of lead-treated and control mice at intervals of 14, 21 and 30 
days after daily intraperitoneal injections of either lead 
nitrate or saline. Total red blood cell and white blood 
cell counts were enumerated using a Coulter automatic cell 
counter. Model A.^ A 0.1-ml aliquot of blood from the lead 
treated and control mice was mixed with 50 ml of a commercial 
2 diluting fluid (Isoton) to make a 1:500 dilution of cell 
suspension. A second dilution equivalent to 1:50,000 was 
made from each 1:500 dilution by transferring 0.2 ml of the 
initial cell suspension into 20 ml of Isoton. Total red 
cell counts were made of the 1:50,000 dilution. Total counts 
of white blood cells were accomplished by adding 0.2 ml of 
a 1% saponin solution to each 1:500 dilution of suspended 
cells. Threshold settings on the Coulter counter for red 
and white blood cell enumeration were those recommended by 
the manufacturer. 
The blood obtained for differential leukocyte counts 
was also collected from the periorbital sinus of lead-
treated and control groups of mice. A drop of blood from 
each mouse was smeared on clean microscopic glass slides. 
^Coulter Diagnostics, Inc., Miami Springs, Fla. 
2 Coulter Diagnostics, Inc., Miami Springs, Fla. 
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The slides were stained with Wright's stain and 100 cells per 
slide were identified. 
Zymosan Assay of 
Properdin 
Symbols and nomenclature of the properdin system 
P Properdin 
RP Serum deficient in properdin 
Z Zymosan 
PZ Properin-zymosan complex 
C' Complement 
C'l First component of C' 
C'2 Second component of C 
C'3 Third component of C * 
C'4 Fourth component of C 
R3 Serum deficient in C'3 
R4 Serum deficient in C'4 
Preparation of reagents 
Human serum Blood from 25 healthy human donors was 
drawn and allowed to stand at room temperature for 2 hours. 
The clot was then rimmed and the blood stored at 4°C over­
night. The serum was separated by centrifugation at 2500 g 
for 20 minutes and recentrifuged under identical conditions 
to remove residual red cells. The clear serum was recovered 
and stored at -70°C until used in the properdin assay. 
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Barbitol buffer solution pH 7.4 
85.0 g NaCl 
5.75 g 5,5-diethylbarbituric acid 
3.75 g sodium^ 5,5-diethylbarbiturate 
5.0 g 0.15M MgClg 
1.5 g 0.15M CaClg 
The ingredients were dissolved in about 500 ml of hot 
distilled water. The solution was cooled, and distilled 
water then added to a final volume of 2 liters. This con­
centrated buffer was stored at 4°C. One part of the buffer 
was added to 4 parts of distilled water before use. The di­
luted buffer was prepared daily and discarded after a 24-
hour period. 
Serum deficient in properdin (HP) A sample of normal 
human serum was brought to and maintained at 17°C in a 
constant temperature bath (the control of temperature is 
extremely important). Temperatures below 15°C result in an 
incomplete removal of properdin from serum, while temperatures 
above 18°C result in increased loss of C'3 activity. Two 
milligrams of commercially prepared zymosan (Lot No. 3216E)^ in 
0.0 8 ml of barbital buffer pH 7.4 was added to each ml of 
serum. The mixture was manually stirred every ten minutes. 
After 1 hour, the mixture was transferred to chilled centrifuge 
^General Biochemicals, Chagrin Falls, Ohio. 
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tubes and centrifuged at 3500 g for 30 minutes at 4 ° C .  The 
clear supernatant fluid was brought to 17°C and 2 mg of 
zymosan in 0.08 ml of barbital buffer was again added with 
stirring to each ml of treated serum. The mixture was in­
cubated at 17°C for 1 hour and centrifuged as before. The 
clear supernatant fluid (RP) was recovered and dispensed in­
to screw-capped glass tubes for storage at -70°C or maintained 
at 4''C for testing within a 12-hour period. 
Preparation of R3 A volume of normal human serum 
was added to an equal volume of barbital buffer pH 7.4. 
Zymosan dissolved in barbital buffer was added to the mixture 
at the rate of 3 mg per ml of normal serum and suspended 
evenly in the serum. The mixture was next incubated at 37°C 
for 60 minutes, with periodic manual mixing. After the incu­
bation period, the mixture was centrifuged at 3000 g for 30 
minutes at 4°C. The clear supernatant fluid was transferred 
to screw-capped glass tubes for storage at -70°C or held at 
4°C for use within a period of 12 hours. 
Standardization of R3 R3 was tested: (a) for lytic 
activity against sensitized sheep red blood cells; (b) for 
anticomplementary properties against small amounts of fresh 
serum; and (c) for its ability to measure C ' 3 in a standard 
RP in the presence or absence of zymosan and in the presence 
or absence of properdin. One-tenth milliliter of R3 should be 
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nonlytic for 1 ml of sensitized sheep red cells. Five one-
hundredths milliliter of R3 should measure at least: (a) 
120 units of C'3 per ml of RP, (b) not less than 90 units 
per ml of RP previously treated with zymosan at 37°C and (c) 
no C'3 in RP previously treated with zymosan in the presence 
of 1 unit of properdin per ml of RP. 
Anti-sheep erythrocyte rabbit serum Glycerinated anti-
sheep hemolysin (amboceptor) was obtained from Baltimore 
Biological Laboratory, Baltimore, Maryland. 
Sensitized sheep erythrocytes Fresh sheep blood was 
collected in an equal volume of sterile Alsever's solution 
(Bukantz et ^ ., 1946) and maintained at 4°C. The blood was 
stored for 4 days before use and discarded after 10 days. 
Sensitized sheep cells were prepared daily, as follows : cells 
were washed twice with 10 volumes of 0.15 M NaCl and then once 
with 10 volumes of barbital buffer pH 7.4. A 2% suspension 
of vashed cells was then made in barbital buffer. One milli­
liter of this suspension was hemolyzed by the addition of 24 
ml of distilled water. The hemoglobin concentration of the 
hemolyzed red cells was determined in a Beckman spectrophoto­
meter^ at a wavelength of 541 my with a violet filter using a 
water blank. The red cell suspension was diluted with 
barbital buffer to contain approximately 5 x 10^ erythrocytes 
per ml of cell suspension by reference to a standard curve 
^Beckman Instruments, Inc., Fullerton, California. 
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relating cell count and O.D. at 541 my. An equal volume of 
barbital buffer, containing 4 units of amboceptor was slowly 
added to the standardized sheep cells with constant swirling 
of the contents. The mixture was then incubated in a water 
bath at 37°C for 15 minutes. The cells were centrifuged as 
before and the supernatant fluid decanted. The cells were 
resuspended in barbital buffer and diluted to approximately 
1.5% when used. The sensitized cells were kept refrigerated 
at 4°C and were usually used within a 12-hour period after 
their preparation. 
Conduct of the assay 
The method of assay for properdin depends upon the re­
quirement for properdin for the inactivation of C'3 by zymosan 
as described by Pillemer and colleagues (1954, 1956). Since 
properdin is not the only factor necessary for this reaction, 
a satisfactory reagent (RP) has to supply all of the other 
factors which participate in the formation of the properdin-
zymosan (PZ) complex and the factor(s) necessary for the in­
activation of C'3 by the PZ complex. In addition, the reagent 
must contain adequate amounts of C'3 and the remaining 
components of complement required for hemolysis of sensitized 
sheep red blood cells (Pillemer ^  al., 1956). 
The assay of properdin is a two stage procedure involv­
ing determination of the smallest volume of test sample which. 
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when incubated for 1 hour at 37°C with constant amounts of RP 
and zymosan/ results in complete inactivation of C'3 in the 
mixture. A typical protocol of initial reaction mixtures as 
used in the experiments described herein is given in Table 
2 .  
Table 2. Typical protocol for titration of properdin 
Tube 
No. RP 
Test 
Sample 
Zymosan 
Suspension 
Barbital 
Buffer 
1 0.1 ml 0.1 ml 1 mg To a 
2 0.1 0.05 1 mg final 
3 0.1 0.025 1 mg volume 
4 0.1 0.01 1 mg of 0-3 ml 
5 0.1 
(1: 
Control 
0.01 
2 dilution) 
1 mg 
6 0.1 0 1 mg To a final 
7 0.1 0 0 volume of 0.3 
ml 
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EXPERIMENTAL PROCEDURES 
AND RESULTS 
Effect of Lead Treatment on Mouse 
Resistance to S_. typhimurium 
Three groups of 25 mice each were formed and housed five 
per cage. Each mouse was given a daily injection of either 
soluble lead nitrate or NSS intraperitoneally (IP) for 30 
days according to the following paradigm: 
Group I - 100 ug lead nitrate in 0.5 ml saline solution 
Group II - 250 ug lead nitrate in 0.5 saline solution 
Group III- 0.5 ml sterile saline solution 
A 4-hour culture of S. typhimurium which had previously 
—3 7 been shown to have an LD^Q of 10 ' was used as the challenge 
g 
agent. The culture contained approximately 10 organisms per 
ml as determined by plate counts. Each group of five mice 
was challenged 24 hours after the final injection of lead or 
saline with a dilution (10 10 10 , 10 or 
10 ^'^) of a 4-hour culture of £. typhimurium. Mice were 
observed daily for signs of illness and mortality. Confirma­
tion of death by S. typhimurium was made by necropsy and 
culture of organs from the dead mice. 
The effect of lead treatment on mouse resistance to 
bacterial challenge is shown in Figure 2. Following challenge 
with £. typhimurium, 54% of mice in Group I but only 13% of 
the control group died within 7 days. All of the mice in 
Figure 2. A graph showing the accumulated mortality of three groups of mice treated 
for 30-days with daily injections of or normal saline solution 
(NSS) and subsequently challenged with S. typhiraurium var. Copenhagen. 
Treatments were as follows : Group I - 100 yg Pb(NOg)g per day, Group II -
250 yg PbfNOgjg per day and Group III - sterile NSS 
100 
/GROUP II 
GROUP I 
TIME (DAYS) 
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Group II, which had received 2-1/2 times more lead nitrate 
than Group I, died by the third day after challenge. At 
termination of the experiment, the mortality was highest in 
mice challenged with the lowest dilutions of bacterial culture. 
The calculated for S_. typhimurium in the control group 
was 10 ^^ while that in Group I was 10 An for 
the mice in Group II could not be determined since all mipe 
died. 
A statistical analysis was performed to compare the 
mortality of mice in the three treatment groups during the 
first 24 hours after challenge. All mice in a group irre­
spective of a dilution of the challenge agent were pooled. 
Table 3 summarizes the statistical comparison between the 
various groups of mice. A chi-square (x ) test indicated a 
highly significant difference (P<0.01) between the lead-
treated and control groups. There was also a highly signifi­
cant difference (P<0.01) between Groups I and II which re­
ceived 100 yg and 250 yg of lead nitrate, respectively. 
To demonstrate that suppressed resistance in Pb(N02)2~ 
treated mice was actually due to lead and not to nitrate, mice 
were again assigned to three groups; two of which received 
concentrations of sodium nitrate calculated to be equivalent 
to the nitrate content of the lead nitrate solutions. The 
third group of mice served as controls and received only 
sterile NSS. All groups of mice received daily intraperitoneal 
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Table 3. Statistical comparisons of Salmonella typhimurium 
challenge in mice exposed to lead nitrate 
Group and Group 2 
Treatment. Comparisons % 
I Group III vs. 
100 yg Lead Nitrate Group I and II 
II Group I vs 
250 ug Lead Nitrate Group II 
III 
Saline Controls 
(P<0.01) 
(P<0.01) 
injections for 30 days and were challenged with a dilution of 
viable S. typhimurium as previously described. The mice were 
observed for mortality for 18 days. The mortality in the 
sodium nitrate-treated groups was no greater than the mor­
tality in the controls. 
Immune Response.of Lead-Treated and Control 
Mice to S. Typhimurium Bacteria 
One-hundred-three mice were used in this study. The 
mice were assigned to four groups. Group I contained 28 
mice and the remaining groups contained 25 mice each. Group 
I received 0.5 ml daily intraperitoneal injections of 100 yg 
of soluble lead nitrate for 14 days. On days 15 and 17, the 
mice received intraperitoneal injections of £. typhimurium 
cells which had previously been killed in 0.35% formaldehyde 
solution and resuspended in sterile NSS. The bacterial sus-
81 
pension (bacterin) was given in 0.2 ml amounts and contained 
g 
approximately 2.4 x 10 bacterial cells as estimated by a 
McFarland standard. Group II mice were treated similarly to 
Group I except that each mouse received 250 yg of lead 
nitrate intraperitoneally in a 0.5-ml dose. After the second 
bacterin injection, both groups were continued on daily 
intraperitoneal injections of soluble lead nitrate for an 
additional two-week period. 
Groups III and IV served as controls for the two lead-
treated groups. Mice in these two groups received daily in­
jections of 0.5 ml of sterile NSS intraperitoneally following 
the same regimen as described for Groups I and II. Group III 
received the two injections of S_. typhimurium bacterin on 
days 15 and 17 and the mice of both control groups were 
continued on sterile NSS for an additional two weeks. 
The state of immunity was ascertained by the presence 
or absence of antibody in blood obtained from the periorbital 
sinus as determined by an agglutination test. The number of 
mice per group, the treatment of the various groups, and the 
sequence of treatments are summarized in Table 4 and the 
results of the experiment are shown in Table 5. More than 80% 
of the mice in the lead-treated groups (I and II) responded 
with serum antibody formation following injection of the S. 
typhimurium bacterin. Ninety-six percent of the immunized 
controls (Group III) also responded to the bacterin prépara-
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Table 4. Protocol for treatment of 
groups of mice 
lead-treated and control 
Days Treatment^ Groups I II III IV 
1-14 100 yg PbfNOgig (0.5 ml) _c -
250 yg PbtNO^jg (0.5 ml) - + -
NSS (0.5 ml) - + + 
15 Agglutination test + + + + 
Salmonella bacterin (0.2 ml) + + + -
16 PbCNOgjg, and NSS as above 
(0.5 ml) + + + + 
17 Salmonella bacterin (0.2 ml) + + + -
18-20 Pb(N02)2 and NSS treatments 
continued daily + + + + 
21 Agglutination test (4 days) + + + + 
22-28 Pb(N02)2 and NSS continued 
daily + + + + 
30 Agglutination test + + + + 
Number of mice 28 25 25 25 
^All injections were given by intraperitoneal route. 
^Treatment received or test performed. 
^Treatment described was not done. 
Table 5. Antibody response of lead-treated and control mice to a typhimurium 
bacterin. The mice were injected with bacterin 15 and 17 days follow­
ing initiation of lead-treatment and antibody titers were determined 
14 days after administration of the bacterin 
Mean tube 
titer of ; Group No. of Responders/ 
No. in group 
% 
Responders 
Range of 
Agglutination 
tube titers Responders Group 
100 g PbtNOglg and S. 
typhimurium bacterin 
24/28 86 1-6 2.5 2.1 
II 
250 g Pb(N03)2 and S. 
typhimurium bacterin 
20/25 80 1-5 2.3 1.9 
III 
Sterile NSS and S. 
typhimurium bacterin 24/25 96 2 - 8  6 . 8  6.5 
IV 
Sterile NSS only 0/25 
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tion; these mice had received no lead. In contrast, none of 
the mice in Group IV which had received only sterile saline 
throughout the 30-day exposure period showed an immune response 
as determined by the agglutination test. 
The mean tube titer of the bacterin-immunized controls 
was much greater than that of either of the lead-treated 
groups (I and II). However, the mice which had received 250 
Vig of lead showed no greater reduction in their mean tube 
titer than did the mice in Group I which had received only 
100 yg of lead. 
To determine whether or not the antibody responses of 
the three groups were significantly different from one another, 
the results were statistically analyzed using the Student's 
"t" test. 
In the calculation, the antibody titers were expressed 
as end-point tube numbers. The dilutions started at 1:5 and 
the last tube with complete agglutination was considered the 
end-point. For example, an antibody titer of 1:160 was 
expressed as tube 6. 
Table 6 summarizes the statistical comparison between 
the various groups of mice. No significant difference was 
observed between Groups I and II (100 and 250 yg of lead 
nitrate respectively) since their mean response to the S. 
typhimurium bacterin was essentially the same. When the 
mean tube titers of either Group I or Group II were compared 
85 
Table 6. Statistical comparisons of lead-treated and control 
mice 14 days after intraperitoneal injections of a 
S_. typhimurium bacterin 
Group and Treatment Group Comparisons P Values 
100 yg PbfNOgig and 
S^. typhimurium bacterin 
I vs II 
No significant 
difference 
II 
250 yg PbfNOgjg and 
S. typhimurium bacterin 
I vs III (P<.001) 
III 
gactlrln II vs III (P<.001) 
IV 
sterile NSS only III vs IV (P<.001) 
with the mean tube titer of Group III, there was a highly 
significant difference (P<.001). There was also an expected 
significant difference between the response of Group IV and 
all of the other groups since this group received only sterile 
NSS and served as a normal negative control group. Figure 3 
graphically compares the serum antibody titrations by the 
agglutination test. 
Figure 3. Mean antibody titers of lead-treated or control 
groups of mice in response to a bacterial in­
jection of formalin-killed S. typhimurium cells 
suspended in sterile 0.85% NaCl solution. A 
dose of bacterin contained approximately 2.4 x 
108 bacterial cells in a 0.2 ml volume. The mean 
antibody titer of each group was determined by 
the bacterial agglutination test conducted on 
serum obtained 14 days following immunization 
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Analysis of Serum Protein Components by Cellulose 
Acetate Electrophoresis 
Serum immunoglobulin patterns determined by electro­
phoresis on cellulose acetate membranes showed that the mean 
values for the alpha^ (a^) and gamma (y) serum components 
of mice receiving lead were significantly reduced as compared 
to normal controls. There was no appreciable differences be­
tween the remaining protein concentrations of lead-treated 
and control groups of mouse serums. Tables 7, 8 and 9 
summarize the calculated serum protein concentrations and mean 
values in grams per hundred ml of the three groups of mice. 
As shown in the data from Tables 7, 8 and 9, there were 
significant differences in the y-globulin levels between the 
various treatment groups. However there was also marked 
individual variation between mice in a particular group. 
These differences are reflected in the patterns pictured in 
Figures 4, 5 and 6. 
Whole Body and Organ Weight Determinations 
of Lead-Treated and Control Mice 
A total of 132 mice were used for determining total lead 
content of the mice. In this study, mice were randomly 
assigned to one of three groups: 
1. A group which was given 100 yg of lead nitrate daily 
for 30 days. 
Figure 4. Comparative electrophoretic patterns of repre­
sentative serums from mice of Group I 
upper left - serum protein pattern of a mouse 
serum 8 days following initiation 
of lead treatment 
upper right- serum protein pattern of a mouse 
serum 12 days following initiation 
of lead treatment 
lower left - serum protein pattern of a mouse 
serum 16 days following initiation 
of lead treatment 
lower right- serum protein pattern of a mouse 
serum 24 days following initiation 
of lead treatment 
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Figure 5. Comparative electrophoretic patterns of repre­
sentative serums from mice of Group II 
upper left - serum protein pattern of a mouse 
serum 8 days following initiation 
of lead treatment 
upper right- serum protein pattern of a mouse 
serum 12 days following initiation 
of lead treatment 
lower left - serum protein pattern of a mouse 
serum 16 days following initiation 
of lead treatment 
lower right- serum protein pattern of a mouse 
serum 24 days following initiation 
of lead treatment 
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Figure 6. Comparative electrophoretic patterns of repre­
sentative serums from control mice in Group III 
upper left - serum protein pattern of a mouse 
serum 8 days following daily in­
jections of sterile normal saline 
solution (NSS) 
upper right- serum protein pattern of a mouse 
serum 12 days following daily in­
jections of sterile NSS 
lower left - serum protein pattern of a mouse 
serum 16 days following daily in­
jections of sterile NSS 
lower right- serum protein pattern of a mouse 
serum 24 days following daily in­
jections of sterile NSS 
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Table 7. Electrophoretic distribution of serums from lead-treated mice in Group 
I as determined by cellulose acetate electrophoresis 
Group I Day^ Total Grams Protein/100 ml 
b Serum 
100 yg PbfNOgig Protein Albumin al «2 B Y 
4 5.62 1.8 .36 1.4 1.1 .31 
8 5.83 2.6 .45 1.1 1.2 .22 
12 4.90 2.7 .43 1.0 1.5 .37 
16 6.10 2.9 .66 1.1 1.1 .42 
20 5.84 2.7 .43 1.1 1.2 .14 
24 6.00 3.0 .51 1.1 1.4 .12 
28 5.86 3.6 .46 .8 1.4 .19 
Mean 5.71 2.7 .47 1.1 1.2 .25 
^Individual mice were exanguinated on day indicated following lead-treatment. 
^Quantitation of serum components were determined by cellulose acetate 
electrophoresis. 
Table 8. Electrophoretic distribution of serums from lead-treated mice in Group 
II as determined by cellulose acetate electrophoresis 
Group II Day® Total Grams Protein/100 ml Serum^ 
250 ug PbfNOgig Protein Albumin al «2 6 Y 
4 5.48 2.1 .52 1.3 1.5 .35 
8 4 .25 2.3 .30 .9 1.1 .20 
12 6.21 3.7 .48 1.4 .9 .21 
16 5.36 3.5 .35 1.1 1.4 .29 
20 5.84 2.6 .39 .9 1.8 .23 
24 4.90 2.2 .50 1.1 1.5 .28 
28 5.48 2.7 .43 1.2 1.5 .28 
Mean 5 .35 2 .6 .43 1.1 1.4 .26 
Individual mice were exanguinated on day indicated following lead-treatment. 
Quantitation of serum components were determined by cellulose acetate 
electrophoresis. 
Table 9. Electrophoretic distribution of serums from control mice in Group III 
as determined by cellulose acetate electrophoresis 
Group III 
Day^ Total Grams Protein/lOO ml Serum^ Saline Controls Protein Albumin al ct2 e Y 
4 6.30 3.0 .51 1.1 1.2 .45 
8 5.86 2.9 .79 1.4 1.6 .57 
12 6 .20 2.9 .75 1. 2 1.2 .48 
16 4.85 2.6 .60 1.1 1.0 .48 
20 5.72 2.5 .40 1.1 1.1 .63 
24 5.84 3.5 .80 1.2 1.1 .52 
28 6 .30 3.1 . 6 6 1.1 1.0 .59 
Mean 5.87 2.9 .64 1.2 1.2 .53 
^Individual mice were exanguinated on day indicated following injections of 
sterile NSS. 
^Quantitation of serum components were determined by cellulose acetate 
electrophoresis. 
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2. A group which was given 250 yg of lead nitrate 
daily for 30 days/ and 
3. A control group which received only sterile NSS. 
Mice from each group were sacrificed on the following 
days of the experiment: 4, 8, 12, 16, 20, 24, and 28. Whole 
body weight and organ weights for brain, spleen, liver and 
kidney were recorded for each mouse. 
The growth (body weight) values are significantly 
(P<.025) different for the three groups. Examination of the 
mean values in Table 10 show that the control group increased 
in weight during the experiment, but Groups I and II are 
changed very little, if at all. On the average, the body 
weight of the Group II mice was less than that of the mice 
in Group I (Table 10) . 
The mean values for the organ weight data are listed in 
Tables 11, 12, 13 and 14. Only in the case of the brain weight 
was there any indication of group differences. On the average, 
the brain weights for Groups I and II were significantly 
(P<.05) larger than the controls. For all groups brain weight 
tended to increase significantly (P<.05) during the experiment. 
No significant changes (P>.10) in the spleen weights were ob­
served. The analysis of the liver date indicated a signifi­
cant (P<.025) increase in liver weight during the experiment, 
but no difference between the groups. The analysis of the 
kidney data shows a significant CP<.005) increase in kidney 
Table 10. Whole body weight determinations in lead-treated and control mice. The 
values were determined as mouse weight in grams at 4-day intervals 
following initiation of lead treatment 
Group 5 12 16 20 24 28 Mean 
100 Ug PbfNOgig 23.7 25.2 24.9 23.3 24.2 23.8 26.5 24.5 
II 
250 yg PbtNO^lg 18.9 22.6 19.5 19.3 24.3 21.9 20.9 21.1 
III 
Sterile NSS 22.6 21.5 24.9 29.1 32.3 30.2 32.5 27.6 
Mean 21.7 23.1 23.1 23.9 26.9 25.3 26.7 
Table 11. Brain weight determination in lead-treated and control mice. The 
values were determined as brain weight in grams of 4-day intervals 
following initiation of lead treatment 
Group -3 5 n Ti5 21 Mean 
I 
100 yg PbfNOgig 0.39 0.43 0.44 0.41 0.44 0.46 0.39 .43 
II 
250 ug PbtNOgig 0.34 0.39 0.43 0.40 0.42 0.40 0.43 .40 
III 
Sterile NSS 0.37 0.34 0.39 0.33 0.42 0.40 0.41 .38 
Mean .37 .39 .42 .38 .43 .42 .41 
Table 12. Spleen weight determination in lead-treated and control mice. The 
values were determined as spleen weight in grams at 4-day intervals 
following initiation of lead treatment 
Gf°up -g g n 16 2Ô 2 A  28" Mean 
100 ug PbfNOgjg 0.09 0.10 0.22 0.14 0.12 0.26 0.20 .16 
II 
250 yg PbfNOgig 0.11 0.13 0.24 0.16 0.12 0.21 0.16 16 
III 
Sterile NSS 0.11 0.13 0.11 0.11 0.12 0.11 0.14 .12 
Mean .10 .12 .19 .13 .12 .19 .17 
Table 13. Liver weight determination in lead-treated and control mice. The 
values were determined as brain weight in grams at 4-day intervals 
following initiation of lead treatment 
f, Dav 5 
4 8 12 16 20 24 2 8 Mean 
100 yg PbfNOgig 1.15 1.41 1.62 1.43 1.58 1.80 1.41 1.49 
II 
250 yg PbtNO^ig 1.13 1.14 1.57 1.24 1.60 1.73 1.52 1.42 
III 
Sterile NSS 1.05 1.32 1.31 1.05 1.58 1.51 1.39 1.32 
Mean 1.11 1.29 1.50 1.24 1.59 1.68 1.44 
Table 14. Kidney weight determination in lead-treated and control mice. The 
values were determined as kidney weight in grams at 4-day intervals 
following initiation of lead treatment 
-4 8 12 16 20 24 28~ Mean 
100 yg PbtNOgig 0.29 0.36 0.39 0.39 0.37 0.39 0.35 .36 
II 
250 yg PbtNOglg 0.22 0.34 0.37 0.34 0.39 0.42 0.36 .35 
III 
Sterile NSS 0.27 0.27 0.33 0.31 0.42 0.38 0.39 .34 
Mean .26 .32 .36 .35 .39 .39 .36 
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weight during the experiment but no difference between the 
groups. There is a suggestion of no further kidney growth 
towards the end of the experiment. 
Lead Retention Studies in Lead-Treated 
and Control Mice 
Mice from the previous experiment were utilized for 
determinations of whole-body lead content. The quantity of 
lead in each animal was calculated in parts per million (PPM) 
as measured by atomic absorption spectrophotometry. Ap­
preciable quantities of lead were retained in the tissues of 
the mice as shown in Table 15. From examination of the mean 
values in Table 11 and application of analysis of variance 
it is apparent that the level of lead did not change over 
time in the control group. Both lead-treated groups had a 
significant (P<.001) increase in the level of lead during the 
course of the experiment. The analysis suggests that the 
time response may not be the same for these two groups. How­
ever, the high level in Group II at the 16th day, the low 
value at the 28th day and the two missing values make it dif­
ficult to interpret the results. There is no doubt, that on 
the average, the level is significantly (P<.001) greater for 
Group II than Group I, but it is not clear just how the dif­
ference changes over time. 
Table 15. Whole body lead determination in lead-treated and control groups of 
mice. The values were determined as parts per million (PPM) of 
lead at 4-day intervals following initiation of lead treatment 
Days V3J.UUP 4 8 12 16 20 24 28 Mean 
I 
100 yg PbfNOglg a 15 .8 16.3 34 .3 25.2 40 .2 56.2 29.0 
II 
250 wg PbfNOglg 35.7 37.8 64.6 83.5 79.1 a 69.4 62.6 
III 
Sterile NSS 0.9 1.1 0.8 1.1 1.6 1.1 0.4 1.0 
Mean 17.4 18.2 27.2 39.6 35.3 36.5 41.9 
^Samples were lost. 
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Gross and Histopathologic Changes 
in Lead-Treated Mice 
Gross and histologic examination of brain, liver, spleen 
and kidney tissues from lead-treated mice revealed no patho­
logic changes. 
Hematology of Lead-Treated and Control Mice 
An experiment was conducted in which the same three ex­
perimental groups were set up and RBC and WBC determinations 
were made at the following times after the start of lead 
treatment: 
1. 14 days: bled prior to 1st bacterin injection 
2. 21 days: bled post 1st bacterin injection, and 
3. 30 days : bled post 2nd bacterin injection 
The animals were injected with a killed suspension of S. 
typhimurium as described in the section "Materials and 
Methods." 
The analysis of the RBC data and examination of the 
mean values in Tables 16, 17, 18 and 19 show that there was 
a significant (P<.001) decrease in the RBC level during the 
experiment for the two groups receiving lead but not for the 
control group. The analysis of the WBC data (Tables 16, 
17 and 18) showed a significant (P<.01) increase in WBC level 
from the beginning to the end of the experiment but there was 
no significant difference between the mean values of the 
Table 16. Total RBC and WBC values of mice in Groups I at 14, 21 and 30 days 
following initiation of treatment with 100 yg/day of PbfNOgjg 
14 days 21 days 30 days 
Mouse Number RBC 
xlO /cmm 
WBC RBC 
xlO /cmm 
WBC RBC 
xl0°/cmm 
WBC 
21 7.84 9,900 8.07 16 ,400 8.92 26 ,700 
22 10.14 5,300 7.95 7,650 7.62 8,500 
23 9.06 9,600 8.74 17 ,000 7.62 15 ,000 
24 9 .45 12,300 8.45 15 ,500 7.80 10 ,400 
25 8.74 9,700 7.23 7,700 7.03 12,800 
26 8.25 12,300 8.07 22,600 7.67 7,300 
27 8.13 7,900 8.20 11,400 7.27 Spilled 
28 9.00 10,300 7.88 11,900 8.20 17,500 
29 8.51 8,739 8.13 9,050 7.92 18,500 
30 8.53 11,800 8.97 16,400 7.49 21,400 
Total 87.65 97,830 81.69 135,600 77.54 138,100 
Mean 8.76 9,783 8.17 13,560 7.75 15,344 
Table 17. Total RBC and WBC values of mice in Group II at 14, 21 and 30 days 
following initiation of treatment with 250 yg/day of PbfNOgjg 
14 days 21 days 30 days 
Mouse Number RBC 
xl06/ 
WBC 
cmm 
RBC 
xl06/ 
WBC 
com 
RBC 
xloG/ 
WBC 
ccm 
31 9.94 9,600 6.45 7,200 8.07 16,400 
32 10.14 10,900 7.91 7,700 8.45 15,500 
33 9.32 16,300 8.05 18,700 7.23 7,700 
34 9 .47 13,700 8.13 6,400 8.07 22,600 
35 8.88 13,100 8.30 11,900 8.20 11,400 
36 8.49 17,300 6.51 20,100 7.91 7,700 
37 8.51 17 ,300 7.81 21,100 8.05 18,700 
38 9 .07 21,000 7.08 19 ,500 6.51 20,100 
39 8.13 7,050 9 .79 12,300 7.81 21,100 
40 8.49 16 ,600 8.56 15,300 7.08 19,500 
Total 90.44 142,850 78.59 140,200 77.38 160,700 
Mean 9.04 14 ,285 7.86 14,020 7.74 16,070 
Table 18. Total RBC and WBC values of mice in Group III at 14, 21 and 30 days 
following daily injections of sterile NSS 
14 days 21 days 30 days 
Mouse Number RBC WBC RBC WBC RBC WBC 
xloG/cmm xlO^/cmm xlO^/crnm 
56 9.14 7,250 8.66 11,400 7.81 13,700 
57 8.02 9,450 7.31 11,000 9.02 10,300 
58 8.51 19,500 8.78 13,800 8.12 15,800 
59 9.44 13,300 8.75 11,500 8.46 18,300 
60 9.04 9,875 7.81 11,200 8.15 19,900 
61 8.84 9,000 7.96 12,100 10.09 13,400 
62 6.31 5,500 8.08 7,800 7.90 19,400 
Total 59.30 73,925 57.35 78,800 59.55 110,800 
Mean 8.48 10,561 8.19 11,257 8.51 15,828 
Table 19. Summary table of mean, total RBC and WBC values in lead-treated and 
control mice at 14, 21 and 30 days following initiation of treatment 
with PbfNO^lg 
Group Treatment 14 days 21 days 30 days Mean 
Red Bloôd Cells X 10 /cmm 
I 100 yg PbtNOy) 2 8 .76 8.17 7.75 8.23 
II 250 yg PbfNOg) 2 9 .04 7.86 7.74 8.21 
III Sterile NSS 8 .48 8.19 8.51 8.39 
Mean 8 .79 8.06 7.94 8.27 
White Blood Cells/cmm 
I 100 yg PbfNOg) 2 9 ,783 13,560 15,120 13,046 
II 250 yg PbfNO^) 
2 14 ,285 14 ,020 16,070 14,792 
III Sterile NSS 10 ,561 11,257 15,829 12,549 
Mean 11 ,652 13,133 15,656 13,583 
Ill 
three groups (Table 19). 
Examination of peripheral leukocyte counts were made at 
time intervals corresponding to sampling periods used in the 
agglutination and total cell count experiment. Five mice 
from each lead-treated group and 2 mice from the saline con­
trols were bled on days 14, 21 and 30. It was hoped that 
some evidence could be found to indicate a typical response 
in relation to lead treatment or bacterial immunization. 
Some investigators have found a lymphocytosis response, while 
others a polymorphonuclear leukocyte response as a result 
of various immunizations (Shechmeister, Paulissen and Yunker, 
1956; and Campbell, 1969). In the present work the difference 
in the differential cell counts seems to be due to fluctuations 
in the lymphocyte and neutrophile leukocyte populations. The 
changes include both depressions and increases over the lympho-
cyte-neutrophile counts as indicated by control animals 
(Tables 20, 21 and 22) . 
Zymosan Assay of Properdin in Lead-Treated 
and Control Mice 
A total of 66 mice was used in the properdin experiments. 
The mice were assigned to three groups as follows: 
Group I - consisted of 21 mice and received daily intra­
peritoneal injections of 100 yg of lead nitrate in 0.5-ml 
amounts for 2 8 days. 
Table 20. Differential leukocyte determinations of lead-treated and control 
mice 14 days following initiation of treatment 
Mouse Number Neutrophils Lymphocytes Monocytes Eosinophils Basophils 
I 
100 yg PblNOgig 
1 48 50 
2  2 6  6 8  
3 38 61 
4 41 57 
5 39 58 
II 
250 yg PbtNO^lg 
1 26 74 
2 11 88 
3 46 54 
4 45 49 
5 36 60 
III 
Saline Controls 
1 33 62 
2 37 62 
2 0 0 
6 0 0 
10 0 
2 0 0 
3 0 0 
0 0 0 
10 0 
0 0 0 
6 0 0 
4 0 0 
5 0 0 
10 0 
Table 21. Differential leukocyte determinations of lead-treated and control mice 
21 days following initiation of treatment 
Mouse Number Neutrophils Lymphocytes Monocytes Eosinophils Basophils 
I 
100 pg PbfNOgig 
1 27 71 
2 28 69 
3 40 58 
4 19 78 
5 31 65 
II 
250 yg PbtNOglg 
1 39 60 
2 40 59 
3 25 73 
4 33 65 
5 44 55 
III 
Saline Controls 
1 21 78 
2 24 76 
2 0 0 
3 0 0 
2 0 0 
3 0 0 
4 0 0 
10 0 
0 10
2 0 0 
2 0 0 
10 0 
10 0 
0 0 0 
Table 22. Differential leukocyte determinations of lead-treated and control mice 
30 days following initiation of treatment 
Mouse Number Neutrophils Lymphcytes Monocytes Eosinophils Basophils 
100 VJg Pb(N02)2 
1 
2 
3 
4 
5 
28 
36 
31 
27 
39 
72 
57 
6 8  
72 
61 
0 
1 
1 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
II 
250 yg Pb(NO 
1 
2 
3 
4 
5 
3^2 
17 
23 
43 
29 
25 
79 
77 
56 
68 
72 
4 
0 
1 
3 
3 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
III 
Saline Controls 
1 
2 
28 
31 
71 
68 
1 
1 
0 
0 
0 
0 
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Group II - consisted of 21 mice and received 250 yg 
daily doses of lead for 28 days. 
Group III - consisted of 24 mice and served as controls. 
Mice of this group received only sterile NSS in 0.5-ml amounts 
for 28 days. Starting at day 0 for the control group and 
every 4 days thereafter for all groups, 3 mice from each group 
were exsanguinated by decapitation under ether anesthesia. 
Generally, 0.5 to 0.8 ml of blood was obtained from each 
animal and blood from each group of 3 mice was pooled to yield 
a single serum specimen for properdin titration. The serums 
were frozen promptly and held at -70°C. 
Properdin Titration 
Serum samples were thawed at room temperature. An 
aliquot of each test sample was diluted 1:4 in barbital buf­
fer pH 7.4. Decreasing volumes of the initial dilutions were 
used to make the reaction mixtures containing RP, zymosan, 
buffer and test sample. The mixtures were incubated for 1 
hour at 37°C and then were centrifuged at 1500 g for 10 
minutes at room temperature. After centrifugation the resi­
dues were discarded and the supernatant fluids tested for 
C'3. Results of the properdin titration for the 3 groups of 
mice are shown in Table 23. 
The number of units of properdin in the test samples 
was calculated from the least volume which would give complete 
Table 23. Properdin titers of lead-treated and control mouse serums 
Group I Group II Group III 
Test Sample Day Bled (100 yg Lead (250 yg Lead (Saline 
Nitrate) Nitrate) Controls) 
(units/ml) 
1 0 ND^ ND ^12^ 
2 4 0 0 16 
3 8 0 0 16 
4 12 0 0 16 
5 16 <6° 8 >24 
6 20 <10 >12 <12 
7 24 ^12 <6 >12 
8 28 8 6 >12 
^ND = not done. 
^2. equal to or greater than. 
equal to or less than. 
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inactivation of C*3 or less than 50% hemolysis in 1 ml of 
RP. For example, if 0.05 ml of test sample was found to be 
the least volume giving no detectable C'3 (complete in­
activation) when incubated with sensitized sheep red blood 
cells and R3, then 0.05 ml of test sample has completely 
inactivated the C'3 in 0.1 ml of RP, or 0.5 ml of test sample 
should completely inactivate the C'3 in 1 ml of RP. The 
properdin titer is the reciprocal of this volume; 1/0.5; 
that is: 2 units/ml. Since the test samples were diluted 
1:4 the properdin titer then becomes 2x4=8 units/ml. 
Extrapolations for properdin units were made on test serums 
which showed partial inactivation of C'3 or less than 50% 
hemolytic activity. 
Control tubes were always set up in parallel with the 
test samples and carried throughout the remainder of all 
procedures. Control tubes were labelled A, B and C. Tube A 
contained 0.1 ml RP + 0.1 ml buffer + 0.1 ml zymosan. This 
tube was used to determine the loss of C*3 in the presence 
of zymosan but in the absence of properdin. Tube B contained 
0.1 ml RP + 0.2 ml buffer. This control determined the con­
centration of C'3 in the RP after incubation, centrifugation, 
etc., but in the absence of properdin and zymosan. Tube C 
contained 1 ml sensitized sheep red blood cells and 0.3 ml 
buffer. This tube served only as a control on the red cells. 
Typical results of the control tubes gave the following 
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approximate values: 
Tube A - >30% hemolysis 
Tube B - >40% hemolysis 
Tube C - No hemolysis 
Since the endpoint in the properdin titration is that 
volume of the sample which, in conjunction with RP and zymo­
san, results in inactivation of all of the C'3 in the reaction 
mixture, it was not necessary to titrate C'3 but merely to 
determine whether it was present or absent. Thus, it was suf­
ficient to test 0.2 ml of each supernatant for C'3 by adding 
0-1 ml of R3 and 1 ml of sensitized sheep cells. The tubes 
for C'3 determination were incubated for 30 minutes at 37°C 
and then centrifuged at 1500 g for 5 minutes at room tempera­
ture. The supernatant fluids were inspected for hemolysis. 
Absence of hemolysis meant complete inactivation of C'3 
in the RP. As previously stated, it was not necessary in 
these studies to titrate C'3 but merely to determine its 
presence or absence by the use of amboceptor-sensitized 
sheep red blood cells. Thus, after incubation of the reac­
tion mixtures at 37°C for 60 minutes, it was sufficient to 
merely test the supernatant fluids for C'3. However, a 
complete C'3 titration was always done on the control samples 
A and B to insure that the RP had a satisfactory C'3 titer, 
both in the presence and absence of zymosan. 
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It should be noted that within 4 days after administra­
tion of lead in both lead-treated groups of mouse seruius, 
properdin activity was completely absent through day 12, while 
serum from the control mice had a properdin titer which ranged 
from 12 to 24 units/ml throughout the experiment. It is also 
seen that on day 16, properdin was demonstrable in both lead-
treated groups of mouse serums and remained present through­
out day 28. With the exception of day 20 for the 250 yg lead-
treated group and day 24 for the 100 ug group, properdin 
titers for both treated groups were decidedly lower than the 
normal values in control serioms. Because all of the test 
serums had initially been diluted 1:4 to provide more volume, 
the question arose as to whether properdin in the lead-
treated serums was indeed completely absent as a result of 
lead treatment or merely reduced and, therefore, not de­
tectable due to the dilution factor. Thus, the assay was 
repeated using undiluted test samples of all serums from day 
4 through day 12. The results of this test were identical 
to those of the diluted samples. Greater than 50% hemolysis 
was found in all dilutions of the test samples of both lead-
treated groups, whereas, properdin titers of control serum 
were within normal limits. This percent hemolysis indicates 
that properdin was not available in the serum of lead-treated 
mice to inactivate C'3 in the reagent for properdin (RP)-
Conversely, C'3 in a standard amount of RP was completely in­
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activated by properdin in the test samples of the control 
serums at various levels of dilution. A complete titration 
of properdin levels of normal serum as performed in this 
experimentation is shown in Tables 24, 25, and 26. 
Table 24. Properdin titration of normal mouse serums 
RP 
(ml) 
Test 
Sample 
(# Day 
Bled) 
Volume 
ml 
(dilution) 
Barbitol 
Buffer 
Zymosan 
(mg) 
R3 
(ml) 
Sensitized 
Sheep 
Cells 
(ml) 
% 
Hemolysis 
Properdin 
units/ml 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #1 0.05 0.050 0.1 0.1 1.0 0 
0.1 Day 0 0 .025 0 .075 0.1 0 .1 1.0 15 >12 
0.1 0.01 0.090 0.1 0.1 1.0 >50 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #2 0 .05 0.050 0.1 0.1 1.0 0 
0.1 Day 4 0 .025 0.075 0.1 0.1 1.0 0 16 
0.1 0 .01 0.090 0.1 0.1 1.0 >50 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #3 0.05 0.050 0.1 0.1 1.0 0 
0.1 Day 8 0.025 0.075 0.1 0.1 1.0 0 16 
0.1 0 .01 0.090 0.1 0.1 1.0 >50 
Table 25. Properdin titration of normal mouse serums 
RP 
(ml) 
Test 
Sample 
(# Day 
Bled) 
Volume 
ml 
(dilution) 
Barbitoi 
Buffer 
Zymosan 
(mg) 
R3 
(ml) 
Sensitized 
Sheep 
Cells 
(ml) 
% 
Hemolysis 
Properdin 
units/ml 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #4 0.05 0.050 0.1 0.1 1.0 0 
0.1 Day 12 0.025 0 .075 0.1 0.1 1.0 0 16 
0.1 0.01 0 .090 0.1 0.1 1.0 >50 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #5 0.05 0.050 0.1 0.1 1.0 0 
0.1 Day 16 0 .025 0.075 0.1 0.1 1.0 0 
0.1 0.01 0 .090 0.1 0.1 1.0 10 >24 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #6 0.05 0.050 0.1 0.1 1.0 0 
0.1 Day 20 0.025 0.075 0.0 0.1 1.0 30 £12 
0.1 0.01 0.090 0.1 0.1 1.0 >50 
Table 26. Properdin titration of normal mouse serums 
RP 
(ml) 
Test 
Sample 
(# Day 
Bled) 
Volume 
ml 
(dilution) 
Barbitoi 
Buffer 
Zymosan 
(mg) 
R3 
(ml) 
Sensitized 
Sheep 
Cells 
(ml) 
% 
Hemolysis 
Properdin 
units/ml 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #7 0.05 0.050 0.1 0.1 1.0 0 
0.1 Day 24 0.025 0.075 0.1 0.1 1.0 10 >12 
0.1 0.01 0.090 0.1 0.1 1.0 >50 
0.1 0.1 (1:4) - 0.1 0.1 1.0 0 
0.1 #8 0 .05 0 .050 0.1 0.1 1.0 0 
0.1 Day 28 0.025 0.075 0.1 0.1 1.0 15 
>12 
0.1 0.01 0 .090 0.1 0.1 1.0 >50 
Test Controls 
0.1 Tube A - 0.1 0.1 0.1 1.0 >30 
0.1 Tube B - 0.2 - 0 .1 1.0 >40 
- Tube C - 0.3 - - 1.0 0 
Table 27. Electrophoretic distribution of serums from AKR and Swiss-Webster 
mice 
Serum Samples Total Protein g/100 ml 
Relative Percentages of Serum Components 
Y B «2 al Albumin 
Normal AKR Serum 5 .36 9.0 24 .2 6.3 8.8 48.5 
AF_^ Serum 
c 4.98 7.4 33.5 17.1 7.5 30.5 
Normal S-W Serum 6.6 8.0 18 18 9.6 44.3 
100 ug PbtNOgjg 5 .93 4.3 21.3 18.1 7.8 46.8 
250 yg Pb (NO^) 2 5.90 4.4 23.8 19.3 7.1 43.6 
- AKR mouse immunized with complete Freunds adjuvant. 
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DISCUSSION 
The increased susceptibility to bacterial infection in 
the absence of clinically observable lead toxicity would be 
of paramount public health significance. A large portion of 
our human and animal population is constantly exposed to 
appreciable quantities of lead due to the presence of this 
element in air, water and food. Lead has long been suspected 
of causing significant changes in normal physiological mech­
anisms at some point short of clinical disease. The study 
described herein was designed to determine the influence of 
subclinical lead exposure on resistance of mice to bacterial 
infection. 
A significant aspect of this study was to determine non-
lethal levels of lead over a 30-day period of treatment and 
to determine the effect of such treatment on the mice. During 
the 30-day period of exposure to "subclinical" amounts of 
lead, none of the mice showed toxic manifestations. Five 
mice died during the exposure period from other causes ; one 
in Group I, two in Group II, and two in the control group. 
Figure 7 shows the healthy appearance of lead-treated and 
control groups of mice 28 days following initiation of the 
various treatments. 
Whole body digestion of lead-treated mice to measure 
lead retention revealed significant concentrations of lead in 
Figure 7. Photographs of lead-treated and control mice 28 
days following initiation of treatment 
top - mice of Group I that received daily in­
jections of 100 yg of 
middle - mice of Group II that received 250 yg 
of PbCNO^)^ 
bottom - control mice of group III that received 
only sterile NSS 
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the body. These concentrations appeared cumulative and 
increased with successive doses of lead nitrate solutions. 
The increased concentrations were also dose-related since more 
than twice as much lead was recovered from mice of the 250 yg 
group than from mice in the 100 yg group at any given time 
throughout the sampling period. Lead absorption from the 
peritoneal cavity was probably quite rapid, with very slow 
excretion and considerable retention of lead by the mice. No 
attempt was made in these studies to evaluate lead excretion 
either in the urine or feces. However, the relatively large 
quantities of lead recovered by the whole body digestion 
technique suggests that an imbalance between lead-intake and 
lead excretion was indeed present. Such an imbalance and the 
inability for the mice to rapidly eliminate small doses of 
lead over a prolonged exposure period would explain the dangers 
of what Patterson (1965) has referred to as "chronic lead 
insult". The cumulative action of lead, therefore, could 
eventually result in altered physiologic activity or in the 
production of signs of lead intoxication. 
In spite of the fact that the lead-treated mice appeared 
completely normal throughout the lead-exposure period, whole 
body weight determinations showed that the mice of both lead-
treated groups were less than those of mice in the control 
group. It appears also that whole body weight of each lead-
treated group was related to the dose of lead administered 
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since the weight of mice that received daily injections of 
250 pg (Group II) of lead was significantly less than that 
of mice in group I which received daily injections of 100 pg 
of lead. Since these mice were immature at the outset of the 
experiment, control animals gained appreciably in body weight 
during the treatment period in contrast to minimal growth in 
lead-treated animals. This observation could indicate that 
exposure to lead, even at subclinical levels, effectively im­
paired certain metabolic functions in the susceptible hosts. 
Similar observations have been reported for rats; Goyer 
et al. (1970) considers a decrease in rate of body-weight 
•gain to be a sensitive indicator of the metabolic effects 
of lead. Possible contributing factors include decreased 
intestinal absorption, uncoupled oxidative phosphorylation 
and excessive loss of urinary amino acids. The latter two 
defects were clearly shown to be operative in rats receiving 
large doses of lead, but changes in these parameters were not 
discernable at the small doses at which decreased weight 
gain became apparent (Goyer et al^. 1970) . 
Histologic examination of the brain, liver, spleen and 
kidney from lead-treated mice revealed no pathologic changes. 
In the absence of demonstrable histologic changes in any of 
the tissues examined and since direct quantitation of lead 
in these specific organs was not determined, no definite 
statements can be made regarding the concentration, or 
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distribution of lead in the various organs at this time. How­
ever, in view of the significant differences between whole 
body weight determinations of lead-treated and control mice, 
it was rather interesting that there were no differences of 
significance between the organ weights of the various groups. 
In fact, the mean organ weight of lead-treated mice were 
slightly greater than those of the controls. The observa­
tion that the growth rate of organs was not affected by the 
lead treatments while body growth rates were significantly 
less them controls might suggest that the relatively small 
amounts of lead as used in these experiments were either not 
toxic for cytoplasmic organelles or, conversely, lead may 
have initiated a very low grade inflammatory or edematous 
response which was not discernable on histologic examination. 
It is well established that heavy metals can combine 
with a large variety of organic molecules by interaction with 
ligands such as sulphydryl, carboxyl, amino, imidazolyl or 
phosphoryl groups (Passow ejt a%. , 1961) . Because of these 
interactions, lead may behave as an inhibitor of various 
enzymes involved in heme biosynthesis. It is therefore 
interesting that several studies have established that some 
important reactions involved in heme biosynthesis take place 
in the mitochondria (Dresdel, 1955; Sano, 1958; Eriksen, 1960). 
Castellino and Aloj (1969) studied the intracellular distribu­
tion of lead-210 in liver and kidney homogenates of rats. They 
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reported that, within a short time after injection of lead, 
the metal was incorporated in all intracellular fractions of 
liver and kidney homogenates obtained by differential centri-
fugation. They concluded that the direct interference by 
lead with some steps in heme biosynthesis (mainly occurring 
in the mitochondria) was probably due to an enzymatic block 
of A-aminolevulinic-dehydrase and heme synthetase. Goyer 
et al. (1970) described intranuclear inclusion bodies as 
related to lead dosage in rats. They were careful to point 
out that the clinical usefulness of this parameter is 
obviously very limited. It is possible, however, to recog­
nize these inclusions in some cases of clinical lead poison­
ing. 
Hematologic changes as a result of subclinical exposure 
to lead was not demonstrated in these experiments. Erythro­
cyte indices as well as leukocyte counts were within normal 
limits. In cases of lead poisoning an anemia may result that 
is usually characterized by microcytosis, hypochromia and 
stippling, accompanied by a variable number of reticulocytes 
(Leiken and Eng, 1963). There have been two views expressed 
as to the primary cause of anemia. Aub et , (1926) , found 
changes in the erythrocyte osmotic fragility after vivo 
and 22, vitro exposure of these cells to lead, and concluded 
that a direct hemolytic effect on the circulating erythrocyte 
was important. Others have felt that lead exerts its 
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hematologic effect primarily upon erythrocyte precursors in 
the bone narrow and that the resultant defective erythrocytes 
are removed from the circulation by the spleen and RES in 
general (McFadzean and Davis, 1949; Pierre, 1952). It is 
highly possible that both mechanisms may be effective but 
anemia or erythrocyte alteration was not observed to result 
from subclinical exposure to lead. 
In investigations of the effects of lead and its com­
pounds on the blood cells, the amount of attention given to 
the effects on the red cells has been far greater than that 
given to the effects on the white cells. Numerous papers 
have appeared dealing with the red-cell anemia, poikilocytosis, 
polychromasia and basophilic stippling. The last mentioned 
phenomenon is very readily recognized, and is one which, al­
though it occurs in other conditions than lead poisoning, is 
still notably characteristic of the malady, at least when 
present to a considerable degree. The significance of 
changes occurring in the white cells has been largely over­
looked or neglected. That there are significant changes has 
even been denied (Shiels, 1950). Possibly as a result of 
the greater attention given to the red cells there have been 
considerable differences of opinion as to whether there are 
any definite changes in the white cells in lead poisoning. 
Normal blood values for the mouse have been compiled by 
Schalm (1965). The differential leukocyte counts for 
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neutrophils, lymphocytes, monocytes and eosinophils are 
26.2, 67.8, 7.5 and 2.0% respectively. In general, the dif­
ferential leukocytes determinations of lead-treated and control 
mice in this study remained within normal limits throughout 
the experiment. The monocyte counts, however, were slightly 
lower than those cited by Schalm (1965) and only one eosino-
phile was demonstrable in Group II. It would appear from 
these results that a sustained lymphocytosis was not apparent 
and that there was no indication that the experimental animals 
were undergoing infection or showing any other atypical leuko­
cytic responses. 
Goadby (1912) stated that in the early stages of lead 
poisoning, more especially in acute cases, distinct leuko­
cytosis was present, with a predominance of lymphocytes. Large 
mononuclear leukocytes were greatly increased in number. He 
further stated that a differential leukocyte count in cases 
of lead poisoning, which also showed the presence of baso­
philic granules, invariably brought to light an increase in 
the percentage of lymphocytes and a decrease in the number of 
polymorphonuclear cells, even when the total leukocyte count 
was not outside normal limits. In his opinion, while an esti­
mation of the total number of red cells and of white cells 
was useful, it was not by any means as valuable as the dif­
ferential leukocyte count and the presence of basophilic 
granules. While other workers reported that.lead produced a _ 
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relative lymphocytosis, this finding was not strikingly demon­
strated by Aiob et al. (1926) in their experimentation. Pepper 
and Farley (1933) stated that there was little effect on the 
leukocytes in clinical cases. 
Bell et / (1925), in considering the effects of lead 
in the treatment of cancer, found slight leukocytosis with 
moderate doses of lead and pronounced leukocytosis and stated 
that slight relative eosinophilia was fairly common. 
McLean (1930), in investigations of the effect of intra­
venous injection of colloidal lead into rabbits, found 
immediate leukocytosis due at first to neutrophilia; after 
eight hours, the numbers of lymphocytes and large mononuclear 
cells began to increase, and in two days reached a higher 
maximum than the granular cells. The lymphocytes exhibited 
a greater response to the lead injections than did the poly­
morphonuclear leukocytes. 
Cantarow and Trumper (1944), after referring to a number 
of authors' conclusions, stated that the great majority of 
observations contradict these specific effects of lead upon 
the relative proportions of the white blood cells in the 
peripheral circulation in uncomplicated cases. 
The scientific literature reveals many studies of the 
biochemical and pathological effects of lead, but only a few 
reports on immunoglobulin alterations associated with lead 
exposure. Sroczynski et al. (1964) studied the serum protein 
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fractions of 60 workers suffering from chronic lead poisoning. 
They found that 10% of the workers showed hypoproteinemia and 
reduction in al globulin. Serum proteins studied by Palmieniak 
and Smolik (1963) in 32 persons exposed to lead revealed a 
reduction in the a-globulin fraction as the main disorder 
noted. Soliman and his colleagues (1970) reported that of 
112 sera from Egyptian workers exposed to lead, 19 showed 
certain biochemical changes. Eight of the 19 cases showed 
complete absence of the yl-globulin fraction, while 11 cases 
showed a great reduction in the yl-globulin fraction. 
In the present work, electrophoretic distribution of 
serum components of normal Swiss-Webster (S-W) strain mice 
showed 5 distinct peaks. They were designated as y, 6, al-
globulin, a2-globulin and albumin. Jordan e^ , (1962) 
electrophoretically characterized serum and ascitic fluid 
from highly inbred AKR mice and described 7 components of 
serum from normal and immunized AKR mice. They included a 
prealbumin component and divided the beta region into two 
components, gl and 62. Table 27 shows the comparative 
distribution of serums from immunized and nonimmunized AKR 
mice used in the experiments of Jordan et (1962) and 
serums from lead-treated and control S-W mice as used in the 
present study. The relative percentages of the 31 and 62 
components for AKR mice have been combined for simplicity in 
comparisons. It can be seen in Table 27 that immunization 
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with antigen-adjuvant mixtures markedly increased the pooled 
relative percentages of a2 and S-globulins in AKR mice as 
compared to AKR normal controls. The percentages of y-
globulin remained relatively unchanged. 
In the present work, continuous exposure of soluble lead 
nitrate to mice in Group I and Group II did not increase the 
relative percentages of a2 or g-globulin components but, in 
contrast, caused a significant reduction of the y-globulin 
components of lead-treated mice as compared with the normal 
saline controls. There was also some reduction of the al 
components of lead-treated mice but no change in the rela­
tive percentages of the remaining fractions. These results, 
however, do not contradict the findings of Jordan's group 
since the antigens used in their work (BSA-Freunds adju­
vant mixture) would have stimulated or enhanced anti­
body formation. This could account for the increase in 
g-globulin concentration. 
The nature of the antigenic stimulation in this study 
would not have been expected to affect electrophoretic pat­
terns appreciably and, if at all, would be expected to in­
crease a- and/or g-globulin concentration. However, since 
y-globulin levels were reduced in lead-treated mice and g-
globulin remained the same as controls, one must assume that 
lead was responsible for reducing y-globulin concentrations. 
137 
As is known, some metals have the propensity to precipi­
tate proteins, and this precipitation apparently is selective 
in nature (Kunkel, 1947). The y-globulins are first affected, 
then other globulins in a definite order. Thus, Williams 
et al. (1954) postulated that if lead can precipitate y -
globulins, this action can also affect the antibody molecules 
since these are y-globulins. 
The results reported here appear consistent with the 
assumptions of Williams e^ a^. (1954) that lead in appropriate 
concentrations can inactivate y-globulins and other serum 
proteins of the antibody system. It can further be assumed 
that if lead can selectively precipitate or bind y-globulins 
then the defense of the body against infectious agents would 
be either greatly reduced or destroyed (/Williams et , 
1954) . 
Continuous exposure of mice to low concentrations of lead 
nitrate during a 30-day period produced no clinical signs of 
lead toxicity but did indicate enhanced susceptibility to 
bacterial infection. Such a conclusion was supported by the 
observation that there was a ten-fold difference in the 
of the S_. typhimurium organisms between the control and the 
lead-treated mice. The susceptibility of the lead-treated 
mice to a strain of S. typhimurium with limited pathogenicity 
was markedly increased. 
The very rapid mortality observed for mice in Group II 
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(all but one died within 24 hours) raises the question of how 
lead may increase susceptibility to S. typhimurium, Selye 
et al. (1966) reported that exposure of rats to lead markedly 
increased their susceptibility to bacterial endotoxin when 
both were given simultaneously. This enhancement effect 
probably does not fully explain the results of the experimen­
tation discussed here. It is doubtful that quantities of 
endotoxin sufficient to kill mice could have been present in 
0.5 ml of a 10 ^ dilution of a 4-hour culture containing 
approximately 500 organisms. Furthermore, more than 24 hours 
elapsed between the last administration of lead nitrate and 
challenge with S_. typhimurium. A more logical explanation 
would be that lead interfered with resistance mechanisms in 
the mice, thereby permitting uninhibited bacterial growth. 
In the mice receiving 250 yg of lead, lethal quantities of 
endotoxin could have been quickly produced in the animal with 
a resultant rapid mortality. In contrast, mice receiving 100 
ug of lead were either not as susceptible to endotoxin or were 
able to restrict somewhat the growth of the bacterial agent. 
Irrespective of which mechanism was operational, there must 
have been a reduced resistance on the part of the exposed 
mice to bacterial multiplication. 
The reduced resistance observed in this experimentation 
could have resulted from the action of lead on one or several 
immunologic mechanisms. Interference with phagocytic activity 
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of polymorphonuclear leukocytes has been reported in cases of 
lead toxicity in man (Rakhimova, 1968) . Lead has also been 
reported to bind antibodies dm vitro (Williams et , 1954) 
and could potentially do so under vivo conditions. This 
ability to bind proteins could also interfere with the func­
tional activity of the properdin system. This experimental 
parameter was investigated in this study and will be dis­
cussed subsequently. 
The antibody response to a typhimurium bacterin as 
determined by a bacterial agglutination test demonstrated a 
marked reduction in serum antibody titers in both lead-treated 
groups of mice as compared to controls. This significant dif­
ference may suggest that antibodies were inactivated by lead 
following production or that lead interfered with antibody 
synthesis. Possibly lead and its compounds when adsorbed into 
the circulation, binds to functional molecules, thereby inter­
fering with vital processes. It is well known that many other 
factors, physical as well as chemical may play a significant 
role in overcoming the resistance of man and animals. For 
example, corticoid deficiency after adrenalectomy or irradia­
tion greatly decreases resistance against various bacterial 
products (Bellanti, 1971). It may be profitable, therefore, 
to explore the possibility that lead may act by interference 
with the function of the pituitary gland, adrenal gland or 
other metabolic phenomena. 
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It is conceivable that low-levels of lead in the body 
may act as a dispersing agent, much in the same fashion as 
urea, causing disruption of noncovalent forces on antibody 
molecules resulting in separation or unfolding of polypeptide 
chains of the molecule with subsequent loss of antibody func­
tion. "Antigen binding" sites or antibody "active sites" on 
immunoglobulin molecules may become blocked or inhibited by 
the action of lead thus interfering with proliferation of 
cells necessary for a complete immune response. Lead is prob­
ably not easily catabolized and daily doses, even at sub­
clinical levels, may have been sufficient to overwhelm the 
capacity of the RES to either phagocytize it or to set in 
motion those factors necessary for adequate antibody synthesis 
and release. 
The administration of low doses of lead produces altera­
tions of major proportions in the properdin levels of mice. 
Properdin activity in both lead-treated groups of mice was 
either completely absent or significantly less than the normal 
properdin values demonstrated in control mice which received 
only sterile NSS. The absence of properdin from day 4 through 
day 12 of both lead-treated groups is apparently due to a 
direct and rapid action of lead and to the affinity that lead 
has for humoral factors of immunologic reactivity. On the 
basis of the results obtained, it may be concluded that lead, 
in subclinical amounts, has the ability to decrease or remove 
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circulating properdin in the early stages following lead 
treatment. Properdin levels either by synthesis or some 
release mechanism, is reestablished during the later stages 
of lead treatment. 
The early absence of properdin may be caused by the 
formation of complexes of this natural protein with the in­
jected lead, thereby allowing removal of properdin from the 
circulation. It is more difficult, however, to explain the 
reoccurrence of properdin titers from day 16 to termination 
of the experiment. Perhaps the hosts by day 16 were able to 
establish a physiologic balance between absorption and ex­
cretion of lead thus becoming "conditioned" to the treatments. 
Thereafter, they were then able to handle lead in such a way 
that properdin titers were either no longer affected or 
affected only to a limited degree. A second possibility is 
that the mice compensated for the loss of properdin by in­
creased synthesis of the immunologic material. Properdin 
titers, however, did not fully return to normal levels 
observed in the controls and could account for observations 
in previous aspects of this work which demonstrated lead-
mediated suppression of antibody formation as well as certain 
alterations in immunoglobulin patterns of lead-treated mice. 
In this study, the absence or presence of properdin was 
not directly correlated with resistance to challenge with 
an infectious agent. It would now be indeed interesting to 
142 
challenge lead-treated mice and controls at a time when 
properdin levels are completely absent, that is, day 4 and 
day 8. Such an experiment would be necessary to demonstrate 
a correlation between normal properdin titers of control mice 
and resistance to certain infections; conversely, between 
absence of reduced properdin titers and susceptibility to 
these infections. Such experimentation is projected. 
It is interesting to note that properdin titers in man 
are reportedly not affected by such factors as age, sex, leuko­
cyte count, abnormal albumin/globulin ratio, or the presence 
of various antibodies (Lepow, 1959). Normal properdin titers 
have been observed in patients with agammaglobulinemia, un­
explained recurrent infection, bronchiectasis, cirrhosis, 
acute leukemia, cortisone tuberculosis, and rheumatoid 
arthritis (Hinz, 1956). Representative patients in non­
terminal stages of various malignancies also had normal proper­
din titers (Hinz, 1956), while terminal patients were found to 
have low properdin titers (Southam and Pillemér, 1957). 
Decreased properdin levels have been observed in patients with 
pneumococcal pneumonia, gram-nsgative infections (pyeloneph­
ritis, Hemophilus influenza, and bacillary dysentery) and 
paroxysmal nocturnal hemoglobinuria. In a few instances, it 
has been possible to correlate properdin titers with the 
clinical course of a given infection. Thus, the properdin 
titers of patients with pneumococcal pneumonia and meningo-
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coccal meningitis fell to very low levels soon after onset 
of their illnesses and gradually returned to normal follow­
ing appropriate therapy (Hinz, 1956). Perhaps, in the 
present investigation, had the animals lived cind lead treat­
ments been terminated, the properdin levels may have re­
turned to normal values. 
The studies outlined and described in this dissertation 
have shown that a general attribute of subclinical levels of 
lead exposure is the ability of lead to alter resistance 
mechanisms in mice. The decreased resistance is associated 
with alterations of several parameters of immunologic 
reactivity. In this sense, lead was capable of upsetting the 
immunologic balance (homeostasis) of exposed animals. What­
ever may be the true underlying mechanism(s) of the capacity 
of lead to reduce resistance and alter immunologic reactivity, 
it is my guess that the lead treatments as administered in 
these studies induced what was comparable to an immunologic 
deficiency state. If this assumption is correct, then 
several major mechanisms of immunity, could have been impaired 
including phagocytosis and the inflammatory response (including 
complement and other aspects of the biologic amplification 
system); antibody responses and cell-mediated (delayed hyper­
sensitivity) responses might also be impaired. 
The complement system has already been described as a 
major biologic amplification system promoting inflammation. 
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phagocytosis and the effects of antibody. A deficiency state 
of any of its 9 components might result in abnormal inflamma­
tory responses or an increased susceptibility to infection. 
Lead is known to affect certain enzymes and interestingly, 
the complement system comprises several enzymes. Lead, then 
could inhibit such enzymes and could interfere with physio­
logic processes thus leading to a complement-deficient state 
of the mice. The lack of hemolytic activity on the part of 
mouse complement precludes the use of that classical procedure 
for titration of complement in mice; therefore, one would need 
to investigate a complement-mediated type of reaction such as 
the properdin system for an evaluation of its activity. 
Enzymes are also particularly inçortant in the killing 
and digestion of microorganisms by phagocytic cells. Further, 
lead could interfere with antibody synthesis by. binding with 
nucleic acids which may be significant in the inductive phase 
of antibody formation. Therefore, the lead-exposed mice were 
incapable of responding to the bacterial immunization as com­
pared to the response observed in nonlead-treated, but im­
munized controls. 
The data have been discussed in relation to an hypothesis 
that the evaluation of immunologic parameters in individuals 
of a population may be a valid procedure for establishing an 
adverse effect from the intake of quantities of lead that do 
not produce clinical illness. The results of this study 
appear consistent with that hypothesis. 
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SUMMARY 
Investigations of the effect of lead on mice demonstrated 
that treatment of mice with daily doses of 100 ug or 250 yg 
of soluble PbfNOgjg for 28-30 days failed to elicit signs of 
clinical toxicity other than failure to gain weight. The mice 
appeared perfectly normal and there were no gross or histo­
logic changes in tissues although appreciable quantities of 
lead were retained. 
The experimentation demonstrated that subclinical levels 
of lead markedly increased susceptibility of the mice to 
challenge with a strain of S. typhimurium. Increased sus­
ceptibility, in the absence of overt clinical signs of lead 
toxicosis, undoubtedly indicated an influence of lead on 
immunologic mechanisms. 
Studies of alterations in immunologic parameters were 
conducted by cellulose acetate electrophoresis of mouse 
serums, by measurement of the response of mice to immunization 
with S. typhimurium bacterin and by determination of properdin 
levels in lead-treated mice. The experiments demonstrated 
that subclinical levels of lead caused a significant reduction 
in a- and y-globulin components of lead-treated mice as com­
pared with normal nonlead-treated controls. Anti typhi­
murium antibody titers were significantly reduced in lead-
treated mice as compared to controls. This result must have 
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reflected the ability of lead to either interfere with anti­
body production or to inactivate antibody. Properdin activity 
in lead-treated mice was either completely absent or markedly 
reduced. 
The enhanced susceptibility or reduced resistance was 
possibly due to one or several of the immunologic mechanisms 
investigated in this study. These observations, collectively, 
provide support to the hypothesis that an immunologic defi­
cient state was induced in mice by exposure to subclinical 
levels of lead. 
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